Abatacept | Injection 125 mg in 1 mL single dose autoinjector | Injection |
| Injection 125 mg in 1 mL single dose pre‑filled syringe | Injection |
Abemaciclib | Tablet 100 mg | Oral |
| Tablet 150 mg | Oral |
| Tablet 50 mg | Oral |
Abiraterone | Tablet containing abiraterone acetate 250 mg | Oral |
| Tablet containing abiraterone acetate 500 mg | Oral |
Acalabrutinib | Capsule 100 mg | Oral |
Acamprosate | Tablet (enteric coated) containing acamprosate calcium 333 mg | Oral |
Acarbose | Tablet 100 mg | Oral |
| Tablet 50 mg | Oral |
Acetazolamide | Tablet 250 mg | Oral |
Aciclovir | Eye ointment 30 mg per g, 4.5 g | Application to the eye |
| Tablet 200 mg | Oral |
| Tablet 800 mg | Oral |
Acitretin | Capsule 10 mg | Oral |
| Capsule 25 mg | Oral |
Aclidinium | Powder for oral inhalation in breath actuated device 322 micrograms (as bromide) per dose, 60 doses | Inhalation by mouth |
Aclidinium with formoterol | Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth |
Adalimumab | Injection 20 mg in 0.2 mL pre-filled syringe | Injection |
| Injection 20 mg in 0.4 mL pre‑filled syringe | Injection |
| Injection 40 mg in 0.4 mL pre-filled pen | Injection |
| Injection 40 mg in 0.4 mL pre-filled syringe | Injection |
| Injection 40 mg in 0.8 mL pre‑filled pen | Injection |
| Injection 40 mg in 0.8 mL pre‑filled syringe | Injection |
| Injection 80 mg in 0.8 mL pre-filled pen | Injection |
| Injection 80 mg in 0.8 mL pre-filled syringe | Injection |
Adapalene with benzoyl peroxide | Gel 1 mg‑25 mg per g, 30 g | Application |
Adrenaline (epinephrine) | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto‑injector | Injection |
| I.M. injection 300 micrograms in 0.3 mL single dose syringe auto‑injector | Injection |
| I.M. injection 500 micrograms in 0.3 mL single dose syringe auto-injector | Injection |
| Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) | Injection |
| Solution for injection 1 mg (as tartrate) in 1 mL (1 in 1,000) | Injection |
Afatinib | Tablet 20 mg | Oral |
| Tablet 30 mg | Oral |
| Tablet 40 mg | Oral |
| Tablet 50 mg | Oral |
Aflibercept | Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre‑filled syringe | Injection |
| Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL) | Injection |
Albendazole | Tablet 200 mg | Oral |
| Tablet 400 mg | Oral |
Alectinib | Capsule 150 mg | Oral |
Alendronic acid | Tablet 70 mg (as alendronate sodium) | Oral |
Alendronic acid with colecalciferol | Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol | Oral |
| Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol | Oral |
Alendronic acid with colecalciferol and calcium | Pack containing 4 tablets containing alendronic acid 70 mg (as alendronate sodium) with 140 micrograms colecalciferol and 48 tablets calcium 500 mg (as carbonate) | Oral |
Alirocumab | Injection 75 mg in 1 mL single use pre-filled pen | Injection |
| Injection 150 mg in 1 mL single use pre-filled pen | Injection |
Allopurinol | Tablet 100 mg | Oral |
| Tablet 300 mg | Oral |
Alogliptin | Tablet 12.5 mg (as benzoate) | Oral |
| Tablet 25 mg (as benzoate) | Oral |
| Tablet 6.25 mg (as benzoate) | Oral |
Alogliptin with metformin | Tablet containing 12.5 mg alogliptin (as benzoate) with 1 g metformin hydrochloride | Oral |
| Tablet containing 12.5 mg alogliptin (as benzoate) with 500 mg metformin hydrochloride | Oral |
| Tablet containing 12.5 mg alogliptin (as benzoate) with 850 mg metformin hydrochloride | Oral |
Alprazolam | Tablet 1 mg | Oral |
| Tablet 250 micrograms | Oral |
| Tablet 500 micrograms | Oral |
Amantadine | Capsule containing amantadine hydrochloride 100 mg | Oral |
Amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids | Oral powder 400 g (Neocate Syneo) | Oral |
Amino acid formula with carbohydrate, vitamins, minerals and trace elements without phenylalanine | Sachets containing oral powder 20 g, 30 (PKU Go) | Oral |
Amino acid formula with carbohydrate without phenylalanine | Tablets containing 0.92 g protein, 462 (PKU Easy Tablet) | Oral |
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine | Bottles containing oral powder 34 g, 30 (PKU Easy Shake & Go) | Oral |
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine | Bottles containing oral powder 34 g, 30 (TYR Easy Shake & Go) | Oral |
Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine, and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (TYR Anamix junior LQ) | Oral |
Amino acid formula with fat, carbohydrate, vitamins, minerals, and trace elements, without methionine and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (HCU Anamix junior LQ) | Oral |
Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides | Oral powder 400 g (Alfamino Junior) | Oral |
| Oral powder 400 g (Neocate Junior) | Oral |
| Oral powder 800 g (Essential Care Jr) | Oral |
Amino acid formula with fat, carbohydrate without methionine | Tablets containing 0.91 g protein, 462 (HCU Easy Tablet) | Oral |
Amino acid formula with fat, carbohydrate without phenylalanine | Tablets (modified release), 70.8 g protein per 100 g, 110 g, 4 (PKU Easy Microtabs) | Oral |
Amino acid formula with fat, carbohydrate without phenylalanine and tyrosine | Tablets containing 0.91 g protein, 462 (TYR Easy Tablet) | Oral |
Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine | Tablets containing 0.91 g protein, 462 (MSUD Easy Tablet) | Oral |
Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Oral powder 400 g (GA1 Anamix infant) | Oral |
| Oral powder 500 g (XLYS, LOW TRY Maxamum) | Oral |
| Sachets containing oral powder 18 g, 30 (GA1 Anamix Junior) | Oral |
| Sachets containing oral powder 24 g, 30 (GA gel) | Oral |
| Sachets containing oral powder 25 g, 30 (GA express 15) | Oral |
Amino acid formula with vitamins and minerals without methionine | Oral liquid 125 mL, 30 (HCU Lophlex LQ 20) | Oral |
| Oral liquid 130 mL, 30 (HCU cooler 15) | Oral |
| Oral liquid 174 mL, 30 (HCU cooler 20) | Oral |
| Oral liquid 87 mL, 30 (HCU cooler 10) | Oral |
| Oral powder 400 g (HCU Anamix infant) | Oral |
| Oral powder 500 g (XMET Maxamum) | Oral |
| Sachets containing oral powder 24 g, 30 (HCU gel) | Oral |
| Sachets containing oral powder 25 g, 30 (HCU express 15) | Oral |
| Sachets containing oral powder 29 g, 30 (HCU Lophlex) | Oral |
| Sachets containing oral powder 36 g, 30 (HCU Anamix Junior) | Oral |
Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Oral powder 400 g (MMA/PA Anamix infant) | Oral |
| Oral powder 500 g (XMTVI Maxamum) | Oral |
| Sachets containing oral powder 18 g, 30 (MMA/PA Anamix Junior) | Oral |
| Sachets containing oral powder 24 g, 30 (MMA/PA gel) | Oral |
| Sachets containing oral powder 25 g, 30 (MMA/PA express 15) | Oral |
Amino acid formula with vitamins and minerals without phenylalanine | Oral gel 85 g, 30 (PKU squeezie) | Oral |
| Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) | Oral |
| Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) | Oral |
| Oral liquid 130 mL, 30 (PKU Air 15) | Oral |
| Oral liquid 130 mL, 30 (PKU Cooler 15) | Oral |
| Oral liquid 174 mL, 30 (PKU Air 20) | Oral |
| Oral liquid 174 mL, 30 (PKU Cooler 20) | Oral |
| Oral liquid 250 mL (Easiphen) | Oral |
| Oral liquid 62.5 mL, 60 (PKU Lophlex LQ 10) | Oral |
| Oral liquid 87 mL, 30 (PKU Cooler 10) | Oral |
| Oral powder 500 g (XP Maxamum) | Oral |
| Oral semi‑solid 109 g, 36 (PKU Lophlex Sensation 20) | Oral |
| Sachets containing oral powder 24 g, 30 (PKU gel) | Oral |
| Sachets containing oral powder 25 g, 30 (PKU express 15) | Oral |
| Sachets containing oral powder 28 g, 30 (PKU Lophlex) | Oral |
| Sachets containing oral powder 34 g, 30 (PKU express 20) | Oral |
| Sachets containing oral powder 36 g, 30 (PKU Anamix Junior) | Oral |
Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Oral liquid 125 mL, 30 (TYR Lophlex LQ 20) | Oral |
| Oral liquid 130 mL, 30 (TYR cooler 15) | Oral |
| Oral liquid 174 mL, 30 (TYR cooler 20) | Oral |
| Oral liquid 87 mL, 30 (TYR cooler 10) | Oral |
| Oral powder 400 g (TYR Anamix infant) | Oral |
| Oral powder 500 g (XPhen, Tyr Maxamum) | Oral |
| Sachets containing oral powder 24 g, 30 (TYR gel) | Oral |
| Sachets containing oral powder 25 g, 30 (TYR express 15) | Oral |
| Sachets containing oral powder 28 g, 30 (TYR Lophlex) | Oral |
| Sachets containing oral powder 34 g, 30 (TYR express 20) | Oral |
| Sachets containing oral powder 36 g, 30 (TYR Anamix Junior) | Oral |
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20) | Oral |
| Oral liquid 130 mL, 30 (MSUD cooler 15) | Oral |
| Oral liquid 174 mL, 30 (MSUD cooler 20) | Oral |
| Oral liquid 87 mL, 30 (MSUD cooler 10) | Oral |
| Oral powder 400 g (MSUD Anamix infant) | Oral |
| Oral powder 500 g (MSUD AID III) | Oral |
| Oral powder 500 g (MSUD Maxamum) | Oral |
| Sachets containing oral powder 24 g, 30 (MSUD gel) | Oral |
| Sachets containing oral powder 25 g, 30 (MSUD express 15) | Oral |
| Sachets containing oral powder 28 g, 30 (MSUD Lophlex) | Oral |
| Sachets containing oral powder 34 g, 30 (MSUD express 20) | Oral |
| Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior) | Oral |
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid | Oral liquid 125 mL, 36 (MSUD Anamix Junior LQ) | Oral |
Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid | Sachets containing oral powder 12.5 g, 30 (PKU Anamix First Spoon) | Oral |
| Sachets containing oral powder 12.5 g, 30 (PKU Explore 5) | Oral |
| Sachets containing oral powder 25 g, 30 (PKU Explore 10) | Oral |
Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine | Oral powder 400 g (PKU Anamix infant) | Oral |
| Oral powder 400 g (PKU Start) | Oral |
Amino acid formula without phenylalanine | Tablets 1 g, 75 (Phlexy‑10) | Oral |
Amino acid formula without valine, leucine and isoleucine | Sachets containing oral powder 6 g, 30 (MSUD amino5) | Oral |
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids | Oral powder 400 g (EleCare LCP) | Oral |
| Oral powder 400 g (Neocate LCP) | Oral |
Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids and medium chain triglycerides | Oral powder 400 g (Alfamino) | Oral |
| Oral powder 400 g (Neocate Gold) | Oral |
Amino acids‑synthetic, formula | Oral powder 400 g (EleCare) | Oral |
| Oral powder 400 g (Neocate Junior Vanilla) | Oral |
Amiodarone | Tablet containing amiodarone hydrochloride 100 mg | Oral |
| Tablet containing amiodarone hydrochloride 200 mg | Oral |
Amisulpride | Oral solution 100 mg per mL, 60 mL | Oral |
| Tablet 100 mg | Oral |
| Tablet 200 mg | Oral |
| Tablet 400 mg | Oral |
Amitriptyline | Tablet containing amitriptyline hydrochloride 10 mg | Oral |
| Tablet containing amitriptyline hydrochloride 25 mg | Oral |
| Tablet containing amitriptyline hydrochloride 50 mg | Oral |
Amlodipine | Tablet 10 mg (as besilate) | Oral |
| Tablet 5 mg (as besilate) | Oral |
Amlodipine with atorvastatin | Tablet 10 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | Oral |
| Tablet 10 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | Oral |
| Tablet 10 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral |
| Tablet 10 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral |
| Tablet 5 mg amlodipine (as besilate) with 10 mg atorvastatin (as calcium) | Oral |
| Tablet 5 mg amlodipine (as besilate) with 20 mg atorvastatin (as calcium) | Oral |
| Tablet 5 mg amlodipine (as besilate) with 40 mg atorvastatin (as calcium) | Oral |
| Tablet 5 mg amlodipine (as besilate) with 80 mg atorvastatin (as calcium) | Oral |
Amlodipine with valsartan | Tablet 10 mg (as besilate)‑160 mg | Oral |
| Tablet 10 mg (as besilate)‑320 mg | Oral |
| Tablet 5 mg (as besilate)‑160 mg | Oral |
| Tablet 5 mg (as besilate)‑320 mg | Oral |
| Tablet 5 mg (as besilate)‑80 mg | Oral |
Amlodipine with valsartan and hydrochlorothiazide | Tablet 10 mg (as besilate)‑160 mg‑12.5 mg | Oral |
| Tablet 10 mg (as besilate)‑160 mg‑25 mg | Oral |
| Tablet 10 mg (as besilate)‑320 mg‑25 mg | Oral |
| Tablet 5 mg (as besilate)‑160 mg‑12.5 mg | Oral |
| Tablet 5 mg (as besilate)‑160 mg‑25 mg | Oral |
Amoxicillin | Capsule 250 mg (as trihydrate) | Oral |
| Capsule 500 mg (as trihydrate) | Oral |
| Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| Powder for oral suspension 500 mg (as trihydrate) per 5 mL, 100 mL | Oral |
| Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL | Oral |
| Tablet 1 g (as trihydrate) | Oral |
Amoxicillin with clavulanic acid | Powder for oral suspension containing 125 mg amoxicillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral |
| Powder for oral suspension containing 400 mg amoxicillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral |
| Tablet containing 500 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral |
| Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral |
Amphotericin B | Lozenge 10 mg | Oral |
Ampicillin | Powder for injection 1 g (as sodium) | Injection |
| Powder for injection 500 mg (as sodium) | Injection |
Amylopectin, modified long chain | Sachets containing oral powder 60 g, 30 (Glycosade) | Oral |
Anastrozole | Tablet 1 mg | Oral |
Apixaban | Tablet 2.5 mg | Oral |
| Tablet 5 mg | Oral |
Apomorphine | Injection containing apomorphine hydrochloride hemihydrate 20 mg in 2 mL | Injection |
| Injection containing apomorphine hydrochloride hemihydrate 50 mg in 5 mL | Injection |
| Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 mL | Injection |
| Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre‑filled pen | Injection |
| Solution for subcutaneous infusion containing apomorphine hydrochloride hemihydrate 50 mg in 10 mL pre-filled syringe | Injection |
Apraclonidine | Eye drops 5 mg (as hydrochloride) per mL, 10 mL | Application to the eye |
Apremilast | Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg | Oral |
| Tablet 30 mg | Oral |
Aprepitant | Capsule 165 mg | Oral |
Arachidonic acid and docosahexaenoic acid with carbohydrate | Sachets of oral powder 4 g containing 200 mg arachidonic acid and 100 mg docosahexaenoic acid, 30 (keyomega) | Oral |
Arginine with carbohydrate | Sachets of oral powder 4 g containing 2 g arginine, 30 (Arginine 2000) | Oral |
| Sachets of oral powder 4 g containing 500 mg arginine, 30 (Arginine 500) | Oral |
| Sachets of oral powder 7.6 g containing 5 g arginine, 30 (Arginine 5000) | Oral |
Aripiprazole | Powder for injection 300 mg (as monohydrate) with diluent | Injection |
| Powder for injection 400 mg (as monohydrate) with diluent | Injection |
| Tablet 10 mg | Oral |
| Tablet 15 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 30 mg | Oral |
Armodafinil | Tablet 150 mg | Oral |
| Tablet 250 mg | Oral |
| Tablet 50 mg | Oral |
Artemether with lumefantrine | Tablet (dispersible) 20 mg‑120 mg | Oral |
| Tablet 20 mg‑120 mg | Oral |
Asenapine | Sublingual wafer 10 mg (as maleate) | Sublingual |
| Sublingual wafer 5 mg (as maleate) | Sublingual |
Aspirin | Tablet 100 mg | Oral |
Atenolol | Oral solution 50 mg in 10 mL, 300 mL | Oral |
| Tablet 50 mg | Oral |
Atomoxetine | Capsule 10 mg (as hydrochloride) | Oral |
| Capsule 100 mg (as hydrochloride) | Oral |
| Capsule 18 mg (as hydrochloride) | Oral |
| Capsule 25 mg (as hydrochloride) | Oral |
| Capsule 40 mg (as hydrochloride) | Oral |
| Capsule 60 mg (as hydrochloride) | Oral |
| Capsule 80 mg (as hydrochloride) | Oral |
Atorvastatin | Tablet 10 mg (as calcium) | Oral |
| Tablet 20 mg (as calcium) | Oral |
| Tablet 40 mg (as calcium) | Oral |
| Tablet 80 mg (as calcium) | Oral |
Atovaquone | Oral suspension 750 mg per 5 mL, 210 mL | Oral |
Atovaquone with proguanil | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral |
Atropine | Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL | Application to the eye |
| Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | Injection |
Auranofin | Capsule 3 mg | Oral |
| Tablet 3 mg | Oral |
Axitinib | Tablet 1 mg | Oral |
| Tablet 5 mg | Oral |
Azathioprine | Tablet 25 mg | Oral |
| Tablet 50 mg | Oral |
Azithromycin | Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL | Oral |
| Tablet 500 mg (as dihydrate) | Oral |
Baclofen | Tablet 10 mg | Oral |
| Tablet 25 mg | Oral |
Balsalazide | Capsule containing balsalazide sodium 750 mg | Oral |
Baricitinib | Tablet 2 mg | Oral |
| Tablet 4 mg | Oral |
Beclometasone | Pressurised inhalation containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation in breath actuated device containing beclometasone dipropionate 100 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation in breath actuated device containing beclometasone dipropionate 50 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Beclometasone with formoterol | Pressurised inhalation containing beclometasone dipropionate 100 micrograms and formoterol fumarate dihydrate 6 micrograms per dose,120 dose | Inhalation by mouth |
Beclometasone with formoterol and glycopyrronium | Pressurised inhalation containing beclometasone dipropionate 100 micrograms with formoterol fumarate dihydrate 6 micrograms and glycopyrronium 10 micrograms (as bromide) per dose, 120 doses | Inhalation by mouth |
Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe | Injection |
| Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre‑filled syringe | Injection |
Benzatropine | Injection containing benzatropine mesilate 2 mg in 2 mL | Injection |
| Tablet containing benzatropine mesilate 2 mg | Oral |
Benzydamine | Mouth and throat rinse containing benzydamine hydrochloride 22.5 mg per 15 mL, 500 mL | Oral application |
Benzylpenicillin | Powder for injection 3 g (as sodium) | Injection |
| Powder for injection 600 mg (as sodium) | Injection |
Betaine | Oral powder 180 g | Oral |
Betamethasone | Cream 200 micrograms (as valerate) per g, 100 g | Application |
| Cream 500 micrograms (as dipropionate) per g, 15 g | Application |
| Cream 500 micrograms (as valerate) per g, 15 g | Application |
| Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection |
| Ointment 500 micrograms (as dipropionate) per g, 15 g | Application |
Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
Bethanechol | Tablet containing bethanechol hydrochloride 10 mg | Oral |
Bicalutamide | Tablet 50 mg | Oral |
Bimatoprost | Eye drops 300 micrograms per mL, 3 mL | Application to the eye |
| Eye drops 300 micrograms per mL, single dose units 0.4 mL, 30 | Application to the eye |
Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL | Application to the eye |
| Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, single dose units 0.4 mL, 30 | Application to the eye |
Binimetinib | Tablet 15 mg | Oral |
Bisacodyl | Enemas 10 mg in 5 mL, 25 | Rectal |
| Suppositories 10 mg, 10 | Rectal |
| Suppositories 10 mg, 12 | Rectal |
| Tablet 5 mg | Oral |
Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral |
| Tablet containing bisoprolol fumarate 2.5 mg | Oral |
| Tablet containing bisoprolol fumarate 5 mg | Oral |
Bivalirudin | Powder for I.V. injection 250 mg (as trifluoroacetate) | Injection |
Brexpiprazole | Tablet 1 mg | Oral |
| Tablet 2 mg | Oral |
| Tablet 3 mg | Oral |
| Tablet 4 mg | Oral |
Brigatinib | Pack containing 7 tablets 90 mg and 21 tablets 180 mg | Oral |
| Tablet 30 mg | Oral |
| Tablet 90 mg | Oral |
| Tablet 180 mg | Oral |
Brimonidine | Eye drops containing brimonidine tartrate 1.5 mg per mL, 5 mL | Application to the eye |
| Eye drops containing brimonidine tartrate 2 mg per mL, 5 mL | Application to the eye |
Brimonidine with timolol | Eye drops containing brimonidine tartrate 2 mg with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
Brinzolamide | Eye drops 10 mg per mL, 5 mL | Application to the eye |
Brinzolamide with brimonidine | Eye drops 10 mg brinzolamide with 2 mg brimonidine tartrate per mL, 5 mL | Application to the eye |
Brinzolamide with timolol | Eye drops 10 mg brinzolamide with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
Brivaracetam | Oral solution 10 mg per mL, 300 mL | Oral |
| Tablet 100 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 50 mg | Oral |
| Tablet 75 mg | Oral |
Brolucizumab | Solution for intravitreal injection 19.8 mg in 0.165 mL pre-filled syringe | Injection |
Bromocriptine | Tablet 2.5 mg (as mesilate) | Oral |
Budesonide | Nebuliser suspension 1 mg in 2 mL single dose units, 30 | Inhalation |
| Nebuliser suspension 500 micrograms in 2 mL single dose units, 30 | Inhalation |
| Powder for oral inhalation in breath actuated device 100 micrograms per dose, 200 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device 200 micrograms per dose, 200 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device 400 micrograms per dose, 200 doses | Inhalation by mouth |
| Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2 | Rectal |
Budesonide with formoterol | Powder for oral inhalation in breath actuated device containing budesonide 100 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses, 2 | Inhalation by mouth |
| Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth |
| Pressurised inhalation containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses | Inhalation by mouth |
| Pressurised inhalation containing budesonide 50 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses | Inhalation by mouth |
Budesonide with glycopyrronium and formoterol | Pressurised inhalation containing budesonide 160 micrograms with glycopyrronium 7.2 micrograms and formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
Buprenorphine | Transdermal patch 10 mg | Transdermal |
| Transdermal patch 15 mg | Transdermal |
| Transdermal patch 20 mg | Transdermal |
| Transdermal patch 25 mg | Transdermal |
| Transdermal patch 30 mg | Transdermal |
| Transdermal patch 40 mg | Transdermal |
| Transdermal patch 5 mg | Transdermal |
Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral |
Busulfan | Tablet 2 mg | Oral |
Cabergoline | Tablet 1 mg | Oral |
| Tablet 2 mg | Oral |
| Tablet 500 micrograms | Oral |
Cabozantinib | Tablet 20 mg | Oral |
| Tablet 40 mg | Oral |
| Tablet 60 mg | Oral |
Calcipotriol with betamethasone | Foam containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 60 g | Application |
| Ointment containing calcipotriol 50 micrograms with betamethasone 500 micrograms (as dipropionate) per g, 30 g | Application |
Calcitonin salmon | Injection 100 I.U. in 1 mL | Injection |
Calcitriol | Capsule 0.25 microgram | Oral |
Calcium | Tablet 600 mg (as carbonate) | Oral |
| Tablet, chewable, 500 mg (as carbonate) | Oral |
Candesartan | Tablet containing candesartan cilexetil 16 mg | Oral |
| Tablet containing candesartan cilexetil 32 mg | Oral |
| Tablet containing candesartan cilexetil 4 mg | Oral |
| Tablet containing candesartan cilexetil 8 mg | Oral |
Candesartan with hydrochlorothiazide | Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral |
Cannabidiol | Oral liquid 100 mg per mL, 100 mL | Oral |
Capecitabine | Tablet 150 mg | Oral |
| Tablet 500 mg | Oral |
Captopril | Oral solution 5 mg per mL, 95 mL | Oral |
Carbamazepine | Oral suspension 100 mg per 5 mL, 300 mL | Oral |
| Tablet 100 mg | Oral |
| Tablet 200 mg | Oral |
| Tablet 200 mg (controlled release) | Oral |
| Tablet 400 mg (controlled release) | Oral |
Carbimazole | Tablet 5 mg | Oral |
Carbohydrate, fat, vitamins, minerals and trace elements | Oral powder 400 g (Energivit) | Oral |
Carbohydrate, fat, vitamins, minerals and trace elements and supplemented with arachidonic acid and docosahexaenoic acid | Sachets containing oral powder 43 g, 30 (basecal 200) | Oral |
Carbomer | Eye gel 2 mg per g, 10 g | Application to the eye |
| Eye gel 2 mg per g, single dose units 0.6 mL, 30 | Application to the eye |
Carbomer 974 | Ocular lubricating gel 3 mg per g, single dose units 0.5 g, 30 | Application to the eye |
Cariprazine | Capsule 1.5 mg | Oral |
| Capsule 3 mg | Oral |
| Capsule 4.5 mg | Oral |
| Capsule 6 mg | Oral |
Carmellose | Eye drops containing carmellose sodium 10 mg per mL, 15 mL | Application to the eye |
| Eye drops containing carmellose sodium 10 mg per mL, single dose units 0.4 mL, 30 | Application to the eye |
| Eye drops containing carmellose sodium 5 mg per mL, 10 mL | Application to the eye |
| Eye drops containing carmellose sodium 5 mg per mL, 15 mL | Application to the eye |
| Eye drops containing carmellose sodium 5 mg per mL, single dose units 0.4 mL, 30 | Application to the eye |
Carmellose with glycerin | Eye drops containing carmellose sodium 5 mg with glycerin 9 mg per mL, 15 mL | Application to the eye |
Carmustine | Implants 7.7 mg, 8 | Implantation |
Carvedilol | Tablet 12.5 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 3.125 mg | Oral |
| Tablet 6.25 mg | Oral |
Cefaclor | Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral |
| Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL | Oral |
| Tablet (sustained release) 375 mg (as monohydrate) | Oral |
Cefalexin | Capsule 250 mg (as monohydrate) | Oral |
| Capsule 500 mg (as monohydrate) | Oral |
| Granules for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL | Oral |
| Granules for oral suspension 250 mg (as monohydrate) per 5 mL, 100 mL | Oral |
Cefazolin | Powder for injection 1 g (as sodium) | Injection |
| Powder for injection 2 g (as sodium) | Injection |
| Powder for injection 500 mg (as sodium) | Injection |
Cefepime | Powder for injection 1 g (as hydrochloride) | Injection |
| Powder for injection 2 g (as hydrochloride) | Injection |
Cefotaxime | Powder for injection 1 g (as sodium) | Injection |
| Powder for injection 2 g (as sodium) | Injection |
Ceftriaxone | Powder for injection 1 g (as sodium) | Injection |
| Powder for injection 2 g (as sodium) | Injection |
| Powder for injection 500 mg (as sodium) | Injection |
Cefuroxime | Powder for oral suspension 125 mg (as axetil) per 5 mL, 100 mL | Oral |
| Tablet 250 mg (as axetil) | Oral |
Celecoxib | Capsule 100 mg | Oral |
| Capsule 200 mg | Oral |
Ceritinib | Capsule 150 mg | Oral |
Certolizumab pegol | Injection 200 mg in 1 mL single use pre‑filled syringe | Injection |
| Solution for injection 200 mg in 1 mL pre‑filled pen | Injection |
Chlorambucil | Tablet 2 mg | Oral |
Chloramphenicol | Eye drops 5 mg per mL, 10 mL | Application to the eye |
Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection |
| Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral |
| Tablet containing chlorpromazine hydrochloride 10 mg | Oral |
| Tablet containing chlorpromazine hydrochloride 100 mg | Oral |
| Tablet containing chlorpromazine hydrochloride 25 mg | Oral |
Chlortalidone | Tablet 25 mg | Oral |
Chorionic gonadotrophin | Injection set containing powder for injection 1,500 units, 3 and solvent 1 mL, 3 | Injection |
Ciclesonide | Pressurised inhalation 160 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation 80 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
Ciclosporin | Capsule 10 mg | Oral |
| Capsule 100 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 50 mg | Oral |
| Eye drops 1 mg per mL, single dose units 0.3 mL, 30 | Application to the eye |
| Oral liquid 100 mg per mL, 50 mL | Oral |
Cinacalcet | Tablet 30 mg (as hydrochloride) | Oral |
| Tablet 60 mg (as hydrochloride) | Oral |
| Tablet 90 mg (as hydrochloride) | Oral |
Ciprofloxacin | Ear drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the ear |
| Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
| Tablet 250 mg (as hydrochloride) | Oral |
| Tablet 500 mg (as hydrochloride) | Oral |
| Tablet 750 mg (as hydrochloride) | Oral |
Citalopram | Tablet 10 mg (as hydrobromide) | Oral |
| Tablet 20 mg (as hydrobromide) | Oral |
| Tablet 40 mg (as hydrobromide) | Oral |
Citrulline | Tablet 1 g, 300 (Citrulline Easy) | Oral |
Citrulline with carbohydrate | Sachets of oral powder 4 g containing 1 g citrulline, 30 (Citrulline 1000) | Oral |
Cladribine | Tablet 10 mg | Oral |
Clarithromycin | Powder for oral liquid 250 mg per 5 mL, 50 mL | Oral |
| Tablet 250 mg | Oral |
Clindamycin | Capsule 150 mg (as hydrochloride) | Oral |
Clobetasol | Shampoo containing clobetasol propionate 500 microgram per mL, 125 mL | Application |
Clomifene | Tablet containing clomifene citrate 50 mg | Oral |
Clomipramine | Tablet containing clomipramine hydrochloride 25 mg | Oral |
Clonazepam | Injection 1 mg in 2 mL (set containing solution 1 mg in 1 mL and 1 mL diluent) | Injection |
| Oral liquid 2.5 mg per mL, 10 mL | Oral |
| Tablet 2 mg | Oral |
| Tablet 500 micrograms | Oral |
Clonidine | Tablet containing clonidine hydrochloride 100 micrograms | Oral |
| Tablet containing clonidine hydrochloride 150 micrograms | Oral |
Clopidogrel | Tablet 75 mg (as besilate) | Oral |
| Tablet 75 mg (as hydrogen sulfate) | Oral |
Clopidogrel with aspirin | Tablet 75 mg (as hydrogen sulfate)‑100 mg | Oral |
Cobimetinib | Tablet 20 mg | Oral |
Codeine | Tablet containing codeine phosphate hemihydrate 30 mg | Oral |
Codeine with paracetamol | Tablet containing codeine phosphate hemihydrate 30 mg with paracetamol 500 mg | Oral |
Colchicine | Tablet 500 micrograms | Oral |
Colestyramine | Sachets containing 4.7 g oral powder (equivalent to 4 g colestyramine), 50 | Oral |
Cortisone | Tablet containing cortisone acetate 25 mg | Oral |
| Tablet containing cortisone acetate 5 mg | Oral |
Crizotinib | Capsule 200 mg | Oral |
| Capsule 250 mg | Oral |
Cromoglycic acid | Pressurised inhalation containing sodium cromoglycate 1 mg per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing sodium cromoglycate 5 mg per dose, 112 doses (CFC‑free formulation) | Inhalation by mouth |
Cyclophosphamide | Tablet 50 mg (anhydrous) | Oral |
Cyproterone | Tablet containing cyproterone acetate 100 mg | Oral |
| Tablet containing cyproterone acetate 50 mg | Oral |
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral |
| Capsule 150 mg (as mesilate) | Oral |
| Capsule 75 mg (as mesilate) | Oral |
Dabrafenib | Capsule 50 mg (as mesilate) | Oral |
| Capsule 75 mg (as mesilate) | Oral |
Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral |
| Capsule containing dantrolene sodium hemiheptahydrate 50 mg | Oral |
Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | Oral |
Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | Oral |
| Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral |
Dapsone | Tablet 100 mg | Oral |
| Tablet 25 mg | Oral |
Daratumumab | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL | Injection |
Darolutamide | Tablet 300 mg | Oral |
Dasatinib | Tablet 100 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 50 mg | Oral |
| Tablet 70 mg | Oral |
Degarelix | Powder for injection 120 mg (as acetate), 2, injection set | Injection |
| Powder for injection 80 mg (as acetate), injection set | Injection |
Denosumab | Injection 120 mg in 1.7 mL | Injection |
| Injection 60 mg in 1 mL pre‑filled syringe | Injection |
Desmopressin | Intranasal solution containing desmopressin acetate 100 micrograms per mL, 2.5 mL dropper bottle | Nasal |
| Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations,
5 mL | Nasal |
| Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations,
5 mL, USP (Apotex) | Nasal |
| Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal |
| Tablet containing desmopressin acetate 200 micrograms | Oral |
| Wafer 120 micrograms (as acetate) | Sublingual |
| Wafer 240 micrograms (as acetate) | Sublingual |
Desvenlafaxine | Tablet (extended release) 100 mg (as succinate) | Oral |
| Tablet (extended release) 50 mg (as succinate) | Oral |
| Tablet (modified release) 100 mg | Oral |
| Tablet (modified release) 100 mg (as benzoate) | Oral |
| Tablet (modified release) 50 mg | Oral |
| Tablet (modified release) 50 mg (as benzoate) | Oral |
Dexamethasone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| Intravitreal injection 700 micrograms | Implantation |
| Tablet 4 mg | Oral |
| Tablet 500 micrograms | Oral |
Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear |
Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg | Oral |
Diazepam | Oral liquid 10 mg per 10 mL, 100 mL | Oral |
| Tablet 2 mg | Oral |
| Tablet 5 mg | Oral |
Diclofenac | Suppository containing diclofenac sodium 100 mg | Rectal |
| Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral |
| Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral |
Dicloxacillin | Capsule 250 mg (as sodium) | Oral |
| Capsule 500 mg (as sodium) | Oral |
Digoxin | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral |
| Tablet 250 micrograms | Oral |
| Tablet 62.5 micrograms | Oral |
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral |
| Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral |
| Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral |
| Tablet containing diltiazem hydrochloride 60 mg | Oral |
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral |
| Capsule (modified release) 240 mg | Oral |
Diphenoxylate with atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral |
Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre‑filled syringe | Injection |
Dipyridamole with aspirin | Capsule 200 mg (sustained release)‑25 mg | Oral |
Disopyramide | Capsule 100 mg | Oral |
Docosahexaenoic acid with carbohydrate | Sachets of oral powder 4 g containing 200 mg docosahexaenoic acid, 30 (docomega) | Oral |
Domperidone | Tablet 10 mg | Oral |
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral |
| Tablet containing donepezil hydrochloride 5 mg | Oral |
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye |
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye |
Dosulepin | Capsule containing dosulepin hydrochloride 25 mg | Oral |
| Tablet containing dosulepin hydrochloride 75 mg | Oral |
Doxepin | Capsule 10 mg (as hydrochloride) | Oral |
| Capsule 25 mg (as hydrochloride) | Oral |
| Tablet 50 mg (as hydrochloride) | Oral |
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral |
| Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral |
| Tablet 100 mg (as hyclate) | Oral |
| Tablet 100 mg (as monohydrate) | Oral |
| Tablet 50 mg (as hyclate) | Oral |
| Tablet 50 mg (as monohydrate) | Oral |
Dulaglutide | Injection 1.5 mg in 0.5 mL single dose pre‑filled pen | Injection |
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral |
| Capsule 60 mg (as hydrochloride) | Oral |
Dupilumab | Injection 200 mg in 1.14 mL single dose pre‑filled syringe | Injection |
| Injection 300 mg in 2 mL single dose pre‑filled syringe | Injection |
Dutasteride | Capsule 500 micrograms | Oral |
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral |
Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral |
Eletriptan | Tablet 40 mg (as hydrobromide) | Oral |
| Tablet 80 mg (as hydrobromide) | Oral |
Empagliflozin | Tablet 10 mg | Oral |
| Tablet 25 mg | Oral |
Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | Oral |
| Tablet containing 25 mg empagliflozin with 5 mg linagliptin | Oral |
Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
| Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | Oral |
| Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | Oral |
Enalapril | Tablet containing enalapril maleate 10 mg | Oral |
| Tablet containing enalapril maleate 20 mg | Oral |
| Tablet containing enalapril maleate 5 mg | Oral |
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral |
Encorafenib | Capsule 50 mg | Oral |
| Capsule 75 mg | Oral |
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti‑Xa) in 1 mL pre‑filled syringe | Injection |
| Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti‑Xa) in 0.2 mL pre‑filled syringe | Injection |
| Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti‑Xa) in 0.4 mL pre‑filled syringe | Injection |
| Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti‑Xa) in 0.6 mL pre‑filled syringe | Injection |
| Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti‑Xa) in 0.8 mL pre‑filled syringe | Injection |
Entacapone | Tablet 200 mg | Oral |
Entrectinib | Capsule 200 mg | Oral |
Enzalutamide | Capsule 40 mg | Oral |
Eplerenone | Tablet 25 mg | Oral |
| Tablet 50 mg | Oral |
Eprosartan | Tablet 400 mg (as mesilate) | Oral |
| Tablet 600 mg (as mesilate) | Oral |
Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | Oral |
Eptifibatide | Solution for I.V. infusion 75 mg (as acetate) in 100 mL | Injection |
| Solution for I.V. injection 20 mg (as acetate) in 10 mL | Injection |
Erlotinib | Tablet 100 mg (as hydrochloride) | Oral |
| Tablet 150 mg (as hydrochloride) | Oral |
| Tablet 25 mg (as hydrochloride) | Oral |
Ertugliflozin | Tablet 15 mg | Oral |
| Tablet 5 mg | Oral |
Ertugliflozin with metformin | Tablet containing 2.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| Tablet containing 2.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
| Tablet containing 7.5 mg ertugliflozin with 1 g metformin hydrochloride | Oral |
| Tablet containing 7.5 mg ertugliflozin with 500 mg metformin hydrochloride | Oral |
Ertugliflozin with sitagliptin | Tablet containing 15 mg ertugliflozin with 100 mg sitagliptin | Oral |
| Tablet containing 5 mg ertugliflozin with 100 mg sitagliptin | Oral |
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral |
| Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral |
| Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral |
Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral |
| Tablet 10 mg (as oxalate) | Oral |
| Tablet 20 mg (as oxalate) | Oral |
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral |
| Capsule (enteric) 40 mg (as magnesium) | Oral |
| Tablet (enteric coated) 20 mg (as magnesium trihydrate) | Oral |
| Tablet (enteric coated) 40 mg (as magnesium trihydrate) | Oral |
Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
| Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral |
Essential amino acids formula | Oral powder 200 g (Essential Amino Acid Mix) | Oral |
Essential amino acids formula with minerals and vitamin c | Oral powder 400 g (Dialamine) | Oral |
Essential amino acids formula with vitamins and minerals | Sachets containing oral powder 12.5 g, 50 (EAA Supplement) | Oral |
Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal |
| Tablet 2 mg | Oral |
| Tablet containing estradiol valerate 1 mg | Oral |
| Tablet containing estradiol valerate 2 mg | Oral |
| Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal |
| Transdermal patches 1.17 mg, 8 | Transdermal |
| Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal |
| Transdermal patches 1.56 mg, 8 | Transdermal |
| Transdermal patches 2 mg, 4 | Transdermal |
| Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal |
| Transdermal patches 3.8 mg, 4 | Transdermal |
| Transdermal patches 390 micrograms, 8 | Transdermal |
| Transdermal patches 5.7 mg, 4 | Transdermal |
| Transdermal patches 585 micrograms, 8 | Transdermal |
| Transdermal patches 7.6 mg, 4 | Transdermal |
| Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal |
| Transdermal patches 780 micrograms, 8 | Transdermal |
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | Oral |
| Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | Oral |
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal |
| Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal |
Estradiol with dydrogesterone | Tablet 1 mg‑5 mg | Oral |
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal |
| Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal |
Estriol | Pessaries 500 micrograms, 15 | Vaginal |
| Vaginal cream 1 mg per g, 15 g | Application |
Etacrynic acid | Tablet 25 mg | Oral |
Etanercept | Injection 50 mg in 1 mL single use auto‑injector, 4 | Injection |
| Injection set containing 4 vials powder for injection 25 mg and 4 pre‑filled syringes solvent 1 mL | Injection |
| Injections 50 mg in 1 mL single use pre‑filled syringes, 4 | Injection |
Ethosuximide | Capsule 250 mg | Oral |
| Oral solution 250 mg per 5 mL, 200 mL | Oral |
Etonogestrel | Subcutaneous implant 68 mg | Implantation |
Etoposide | Capsule 100 mg | Oral |
| Capsule 50 mg | Oral |
Everolimus | Tablet 0.25 mg | Oral |
| Tablet 0.5 mg | Oral |
| Tablet 0.75 mg | Oral |
| Tablet 1 mg | Oral |
| Tablet 10 mg | Oral |
| Tablet 2.5 mg | Oral |
| Tablet 5 mg | Oral |
| Tablet, dispersible, 2 mg | Oral |
| Tablet, dispersible, 3 mg | Oral |
| Tablet, dispersible, 5 mg | Oral |
Evolocumab | Injection 140 mg in 1 mL single use pre‑filled pen | Injection |
| Injection 420 mg in 3.5 mL single use pre‑filled cartridge | Injection |
Exemestane | Tablet 25 mg | Oral |
Exenatide | Injection solution 10 micrograms per dose in pre‑filled pen, 60 doses | Injection |
| Injection solution 5 micrograms per dose in pre‑filled pen, 60 doses | Injection |
Ezetimibe | Tablet 10 mg | Oral |
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral |
| Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral |
Ezetimibe with atorvastatin | Tablet 10 mg‑10 mg | Oral |
| Tablet 10 mg‑20 mg | Oral |
| Tablet 10 mg‑40 mg | Oral |
| Tablet 10 mg‑80 mg | Oral |
Ezetimibe with simvastatin | Tablet 10 mg‑10 mg | Oral |
| Tablet 10 mg‑20 mg | Oral |
| Tablet 10 mg‑40 mg | Oral |
| Tablet 10 mg‑80 mg | Oral |
Famciclovir | Tablet 125 mg | Oral |
| Tablet 250 mg | Oral |
| Tablet 500 mg | Oral |
Famotidine | Tablet 20 mg | Oral |
| Tablet 40 mg | Oral |
Febuxostat | Tablet 80 mg | Oral |
Felodipine | Tablet 10 mg (extended release) | Oral |
| Tablet 2.5 mg (extended release) | Oral |
| Tablet 5 mg (extended release) | Oral |
Fenofibrate | Tablet 145 mg | Oral |
| Tablet 48 mg | Oral |
Fentanyl | Lozenge 1200 micrograms (as citrate) | Buccal |
| Lozenge 1600 micrograms (as citrate) | Buccal |
| Lozenge 200 micrograms (as citrate) | Buccal |
| Lozenge 400 micrograms (as citrate) | Buccal |
| Lozenge 600 micrograms (as citrate) | Buccal |
| Lozenge 800 micrograms (as citrate) | Buccal |
| Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal |
| Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal |
| Tablet (orally disintegrating) 400 micrograms (as citrate) | Buccal |
| Tablet (orally disintegrating) 600 micrograms (as citrate) | Buccal |
| Tablet (orally disintegrating) 800 micrograms (as citrate) | Buccal |
| Tablet (sublingual) 100 micrograms (as citrate) | Sublingual |
| Tablet (sublingual) 200 micrograms (as citrate) | Sublingual |
| Tablet (sublingual) 300 micrograms (as citrate) | Sublingual |
| Tablet (sublingual) 400 micrograms (as citrate) | Sublingual |
| Tablet (sublingual) 600 micrograms (as citrate) | Sublingual |
| Tablet (sublingual) 800 micrograms (as citrate) | Sublingual |
| Transdermal patch 1.28 mg | Transdermal |
| Transdermal patch 10.20 mg | Transdermal |
| Transdermal patch 12.375 mg | Transdermal |
| Transdermal patch 12.6 mg | Transdermal |
| Transdermal patch 16.5 mg | Transdermal |
| Transdermal patch 16.8 mg | Transdermal |
| Transdermal patch 2.063 mg | Transdermal |
| Transdermal patch 2.1 mg | Transdermal |
| Transdermal patch 2.55 mg | Transdermal |
| Transdermal patch 4.125 mg | Transdermal |
| Transdermal patch 4.2 mg | Transdermal |
| Transdermal patch 5.10 mg | Transdermal |
| Transdermal patch 7.65 mg | Transdermal |
| Transdermal patch 8.25 mg | Transdermal |
| Transdermal patch 8.4 mg | Transdermal |
Ferric carboxymaltose | Injection 1000 mg (iron) in 20 mL | Injection |
| Injection 500 mg (iron) in 10 mL | Injection |
Ferric derisomaltose | Injection 500 mg (iron) in 5 mL | Injection |
| Injection 1000 mg (iron) in 10 mL | Injection |
Ferrous fumarate | Tablet 200 mg (equivalent to 65.7 mg iron) | Oral |
Ferrous fumarate with folic acid | Tablet 310 mg (equivalent to 100 mg iron)‑350 micrograms | Oral |
Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral |
Fingolimod | Capsule 250 micrograms (as hydrochloride) | Oral |
| Capsule 500 micrograms (as hydrochloride) | Oral |
Flecainide | Tablet containing flecainide acetate 100 mg | Oral |
| Tablet containing flecainide acetate 50 mg | Oral |
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral |
| Capsule 500 mg (as sodium monohydrate) | Oral |
| Powder for injection 1 g (as sodium monohydrate) | Injection |
| Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
| Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral |
Fluconazole | Capsule 100 mg | Oral |
| Capsule 200 mg | Oral |
| Capsule 50 mg | Oral |
| Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral |
| Solution for I.V. infusion 200 mg in 100 mL | Injection |
| Solution for I.V. infusion 400 mg in 200 mL | Injection |
Fludarabine | Tablet containing fludarabine phosphate 10 mg | Oral |
Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral |
Fluorometholone | Eye drops 1 mg per mL, 5 mL | Application to the eye |
| Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL | Application to the eye |
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral |
| Tablet, dispersible, 20 mg (as hydrochloride) | Oral |
Flupentixol decanoate | Oily I.M. injection 100 mg in 1 mL | Injection |
| Oily I.M. injection 20 mg in 1 mL | Injection |
Flutamide | Tablet 250 mg | Oral |
Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses | Inhalation by mouth |
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth |
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC‑free formulation) | Inhalation by mouth |
Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | Oral |
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral |
| Tablet containing fluvoxamine maleate 50 mg | Oral |
Folic acid | Tablet 5 mg | Oral |
| Tablet 500 micrograms | Oral |
Folinic acid | Injection containing calcium folinate equivalent to 100 mg folinic acid in 10 mL | Injection |
| Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection |
| Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral |
Follitropin alfa | Injection 150 I.U. in 0.25 mL pre‑filled pen | Injection |
| Injection 225 I.U. in 0.375 mL pre‑filled pen | Injection |
| Injection 300 I.U. in 0.5 mL multi‑dose cartridge | Injection |
| Injection 450 I.U. in 0.75 mL multi‑dose cartridge | Injection |
| Injection 75 I.U. in 0.125 mL pre‑filled pen | Injection |
| Injection 900 I.U. in 1.5 mL multi‑dose cartridge | Injection |
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi‑dose cartridge | Injection |
| Solution for injection 600 I.U. in 0.72 mL multi‑dose cartridge | Injection |
| Solution for injection 900 I.U. in 1.08 mL multi‑dose cartridge | Injection |
Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre‑filled syringe | Injection |
Formoterol | Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth |
| Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth |
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection |
Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral |
| Tablet containing fosinopril sodium 20 mg | Oral |
Fosinopril with hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg | Oral |
Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear |
Fremanezumab | Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe | Injection |
Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection |
Furosemide | Injection 20 mg in 2 mL | Injection |
| Oral solution 10 mg per mL, 30 mL | Oral |
| Tablet 20 mg | Oral |
| Tablet 40 mg | Oral |
| Tablet 500 mg | Oral |
Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral |
Gabapentin | Capsule 100 mg | Oral |
| Capsule 300 mg | Oral |
| Capsule 400 mg | Oral |
| Tablet 600 mg | Oral |
| Tablet 800 mg | Oral |
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral |
| Capsule (prolonged release) 24 mg (as hydrobromide) | Oral |
| Capsule (prolonged release) 8 mg (as hydrobromide) | Oral |
Galcanezumab | Injection 120 mg in 1 mL pre-filled pen | Injection |
Gefitinib | Tablet 250 mg | Oral |
Gemfibrozil | Tablet 600 mg | Oral |
Gentamicin | Eye drops 3 mg (as sulfate) per mL, 5 mL | Application to the eye |
| Injection 80 mg (as sulfate) in 2 mL | Injection |
Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre‑filled syringe | Injection |
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral |
Glibenclamide | Tablet 5 mg | Oral |
Gliclazide | Tablet 30 mg (modified release) | Oral |
| Tablet 60 mg (modified release) | Oral |
| Tablet 80 mg | Oral |
Glimepiride | Tablet 1 mg | Oral |
| Tablet 2 mg | Oral |
| Tablet 3 mg | Oral |
| Tablet 4 mg | Oral |
Glipizide | Tablet 5 mg | Oral |
Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection |
Glucose and ketone indicator‑urine | Test strips, 50 (Keto‑Diastix) | For external use |
Glucose indicator‑urine | Test strips, 50 (Diastix) | For external use |
Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual |
| Transdermal patch 18 mg | Transdermal |
| Transdermal patch 25 mg | Transdermal |
| Transdermal patch 36 mg | Transdermal |
| Transdermal patch 50 mg | Transdermal |
| Transdermal patch 54 mg | Transdermal |
Glycine with carbohydrate | Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500) | Oral |
Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine | Sachets containing oral powder 31 g, 30 (Tylactin Build 20) | Oral |
| Sachets containing oral powder 35 g, 30 (TYR Sphere20) | Oral |
Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 14 (Tylactin Complete) | Oral |
| Bars 81 g, 7 (Camino Pro Complete) | Oral |
| Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite) | Oral |
| Oral liquid 250 mL, 30 (PKU Glytactin RTD 15) | Oral |
| Oral liquid 250 mL, 30 (Tylactin RTD) | Oral |
| Sachets containing oral powder 16 g, 60 (PKU Build 10) | Oral |
| Sachets containing oral powder 20 g, 60 (PKU Restore) | Oral |
| Sachets containing oral powder 32 g, 30 (PKU Build 20) | Oral |
| Sachets containing oral powder 49 g, 30 (Camino Pro Bettermilk) | Oral |
| Sachets containing oral powder 51 g, 30 (PKU Bettermilk Lite) | Oral |
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Oral liquid 250 mL, 18 (PKU GMPro LQ) | Oral |
| Sachets containing oral powder 27 g, 30 (PKU Sphere15) | Oral |
| Sachets containing oral powder 35 g, 30 (PKU Sphere20) | Oral |
Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
Golimumab | Injection 100 mg in 1 mL single use pre‑filled pen | Injection |
| Injection 50 mg in 0.5 mL single use pre‑filled pen | Injection |
| Injection 50 mg in 0.5 mL single use pre‑filled syringe | Injection |
Goserelin | Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre‑filled injection syringe | Implantation |
| Subcutaneous implant 3.6 mg (as acetate) in pre‑filled injection syringe | Implantation |
Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
| Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre‑filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral |
| Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre‑filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral |
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection |
| Tablet 2 mg (as hydrochloride) | Oral |
Griseofulvin | Tablet 125 mg | Oral |
| Tablet 500 mg | Oral |
Guanfacine | Tablet 1 mg (as hydrochloride) | Oral |
| Tablet 2 mg (as hydrochloride) | Oral |
| Tablet 3 mg (as hydrochloride) | Oral |
| Tablet 4 mg (as hydrochloride) | Oral |
Guselkumab | Injection 100 mg in 1 mL single use pre-filled pen | Injection |
| Injection 100 mg in 1 mL single use pre‑filled syringe | Injection |
Haloperidol | Injection 5 mg in 1 mL | Injection |
| Oral solution 2 mg per mL, 100 mL | Oral |
| Tablet 1.5 mg | Oral |
| Tablet 5 mg | Oral |
| Tablet 500 micrograms | Oral |
Haloperidol decanoate | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection |
| I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection |
Heparin | Injection (preservative‑free) 5,000 I.U. (as sodium) in 5 mL | Injection |
| Injection 5,000 units (as sodium) in 0.2 mL | Injection |
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 200 mL, 32 (KetoCal 4:1 LQ) | Oral |
| Oral liquid 250 mL, 30 (KetoVie 3:1) | Oral |
| Oral liquid 250 mL, 30 (KetoVie 4:1) | Oral |
| Oral powder 300 g (KetoCal 3:1) | Oral |
| Oral powder 300 g (KetoCal 4:1) | Oral |
| Oral semi-solid 100 g, 36 (K.Yo) | Oral |
Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | Application to the eye |
| Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | Application to the eye |
Hydralazine | Tablet containing hydralazine hydrochloride 25 mg | Oral |
| Tablet containing hydralazine hydrochloride 50 mg | Oral |
Hydrochlorothiazide | Tablet 25 mg | Oral |
Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral |
Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application |
| Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye |
| Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection |
| Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection |
| Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application |
| Rectal foam containing hydrocortisone acetate 90 mg per applicatorful, 14 applications, aerosol 21.1 g | Rectal |
| Tablet 20 mg | Oral |
| Tablet 4 mg | Oral |
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection |
| Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection |
| Oral liquid containing hydromorphone hydrochloride 1 mg per mL, 200 mL | Oral |
| Oral solution containing hydromorphone hydrochloride 1 mg per mL, 473 mL | Oral |
| Tablet (modified release) containing hydromorphone hydrochloride 16 mg | Oral |
| Tablet (modified release) containing hydromorphone hydrochloride 32 mg | Oral |
| Tablet (modified release) containing hydromorphone hydrochloride 4 mg | Oral |
| Tablet (modified release) containing hydromorphone hydrochloride 64 mg | Oral |
| Tablet (modified release) containing hydromorphone hydrochloride 8 mg | Oral |
| Tablet containing hydromorphone hydrochloride 2 mg | Oral |
| Tablet containing hydromorphone hydrochloride 4 mg | Oral |
| Tablet containing hydromorphone hydrochloride 8 mg | Oral |
Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection |
| Injection 1 mg (as chloride) in 1 mL | Injection |
Hydroxycarbamide | Capsule 500 mg | Oral |
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral |
Hydroxyethyl starch 130/0.4 | I.V. infusion 30 g per 500 mL, 500 mL | Injection |
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection |
Hypromellose | 0.3% w/v eye drops, 10 mL (preservative free) | Application to the eye |
| Eye drops 3 mg per mL, 10 mL | Application to the eye |
| Eye drops 5 mg per mL, 15 mL | Application to the eye |
Hypromellose with carbomer 980 | Ocular lubricating gel 3 mg‑2 mg per g, 10 g | Application to the eye |
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 2900 with 1 mg dextran 70 per mL, single dose units 0.4 mL, 28 | Application to the eye |
| Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye |
Ibandronic acid | Tablet 50 mg (as ibandronate sodium monohydrate) | Oral |
Ibrutinib | Capsule 140 mg | Oral |
Ibuprofen | Tablet 400 mg | Oral |
Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre‑filled syringe | Injection |
Idelalisib | Tablet 100 mg | Oral |
| Tablet 150 mg | Oral |
Imatinib | Capsule 100 mg (as mesilate) | Oral |
| Capsule 400 mg (as mesilate) | Oral |
| Tablet 100 mg (as mesilate) | Oral |
| Tablet 400 mg (as mesilate) | Oral |
Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral |
| Tablet containing imipramine hydrochloride 10 mg USP | Oral |
| Tablet containing imipramine hydrochloride 25 mg | Oral |
| Tablet containing imipramine hydrochloride 25 mg USP | Oral |
Imiquimod | Cream 50 mg per g, 2 g, 2 | Application |
| Cream 50 mg per g, 250 mg single use sachets, 12 | Application |
Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
| Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth |
Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth |
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler) | Inhalation by mouth |
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler) | Inhalation by mouth |
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 62.5 micrograms (for use in Breezhaler) | Inhalation by mouth |
| Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 127.5 micrograms (for use in Breezhaler) | Inhalation by mouth |
| Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 260 micrograms (for use in Breezhaler) | Inhalation by mouth |
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral |
| Tablet containing indapamide hemihydrate 2.5 mg | Oral |
Indometacin | Capsule 25 mg | Oral |
| Suppository 100 mg | Rectal |
Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection |
| Solution for injection 120 mg in 1 mL pre-filled syringe | Injection |
Insect allergen extract‑honey bee venom | Injection set containing 550 micrograms | Injection |
| Injection set containing 550 micrograms with diluent | Injection |
Insect allergen extract‑paper wasp venom | Injection set containing 550 micrograms | Injection |
| Injection set containing 550 micrograms with diluent | Injection |
Insect allergen extract‑yellow jacket venom | Injection set containing 550 micrograms | Injection |
| Injection set containing 550 micrograms with diluent | Injection |
Insulin aspart | Injection (human analogue) (fast acting) 100 units per mL, 10 mL vial | Injection |
| Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| Injections (human analogue) (fast acting), pre‑filled pen, 100 units per mL, 3 mL, 5 | Injection |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units‑70 units per mL, 3 mL, 5 | Injection |
Insulin degludec with insulin aspart | Injections, cartridges, 70 units‑30 units per mL, 3 mL, 5 | Injection |
| Injections, pre‑filled pen, 70 units‑30 units per mL, 3 mL, 5 | Injection |
Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection |
Insulin glulisine | Injection (human analogue) 100 units per mL, 10 mL | Injection |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
Insulin isophane | Injection (human) 100 units per mL, 10 mL | Injection |
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
Insulin lispro | Injection (human analogue) 100 units per mL, 10 mL vial | Injection |
| Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection |
| Injections (human analogue), pre‑filled pen, 200 units per mL, 3 mL, 5 | Injection |
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units‑75 units per mL, 3 mL, 5 | Injection |
| Injections (human analogue), cartridges, 50 units‑50 units per mL, 3 mL, 5 | Injection |
Insulin neutral | Injection (human) 100 units per mL, 10 mL | Injection |
| Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection |
Insulin neutral with insulin isophane | Injection (human) 30 units‑70 units per mL, 10 mL | Injection |
| Injections (human), cartridges, 30 units‑70 units per mL, 3 mL, 5 | Injection |
| Injections (human), cartridges, 50 units‑50 units per mL, 3 mL, 5 | Injection |
Interferon beta‑1a | Injection 30 micrograms (6,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe | Injection |
| Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose autoinjector | Injection |
| Injection 44 micrograms (12,000,000 I.U.) in 0.5 mL single dose pre‑filled syringe | Injection |
| Solution for injection 132 micrograms in 1.5 mL multidose cartridge | Injection |
Interferon beta‑1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection |
Ipratropium | Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation |
| Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation |
| Pressurised inhalation containing ipratropium bromide monohydrate 21 micrograms per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Irbesartan | Tablet 150 mg | Oral |
| Tablet 300 mg | Oral |
| Tablet 75 mg | Oral |
Irbesartan with hydrochlorothiazide | Tablet 150 mg‑12.5 mg | Oral |
| Tablet 300 mg‑12.5 mg | Oral |
| Tablet 300 mg‑25 mg | Oral |
Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection |
Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection |
Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000) | Oral |
| Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50) | Oral |
Isoniazid | Tablet 100 mg | Oral |
Isosorbide dinitrate | Tablet 5 mg (sublingual) | Oral |
Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral |
| Tablet 60 mg (sustained release) | Oral |
Isotretinoin | Capsule 10 mg | Oral |
| Capsule 20 mg | Oral |
| Capsule 30 mg | Oral |
| Capsule 40 mg | Oral |
| Capsule 5 mg | Oral |
Itraconazole | Capsule 100 mg | Oral |
| Capsule 50 mg | Oral |
Ivabradine | Tablet 5 mg (as hydrochloride) | Oral |
| Tablet 7.5 mg (as hydrochloride) | Oral |
Ivermectin | Tablet 3 mg | Oral |
Ixekizumab | Injection 80 mg in 1 mL single dose pre‑filled pen | Injection |
Ketoconazole | Cream 20 mg per g, 30 g | Application |
| Shampoo 20 mg per g, 60 mL | Application |
Ketoprofen | Capsule 200 mg (sustained release) | Oral |
Labetalol | Tablet containing labetalol hydrochloride 100 mg | Oral |
| Tablet containing labetalol hydrochloride 200 mg | Oral |
Lacosamide | Oral solution 10 mg per mL, 200 mL | Oral |
| Tablet 100 mg | Oral |
| Tablet 150 mg | Oral |
| Tablet 200 mg | Oral |
| Tablet 50 mg | Oral |
Lamotrigine | Tablet 100 mg | Oral |
| Tablet 200 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 5 mg | Oral |
| Tablet 50 mg | Oral |
Lansoprazole | Capsule 15 mg | Oral |
| Capsule 30 mg | Oral |
| Tablet 15 mg (orally disintegrating) | Oral |
| Tablet 30 mg (orally disintegrating) | Oral |
Lanthanum | Tablet, chewable, 1000 mg (as carbonate hydrate) | Oral |
| Tablet, chewable, 500 mg (as carbonate hydrate) | Oral |
| Tablet, chewable, 750 mg (as carbonate hydrate) | Oral |
Lapatinib | Tablet 250 mg (as ditosilate monohydrate) | Oral |
Latanoprost | Eye drops 50 micrograms per mL, 2.5 mL | Application to the eye |
Latanoprost with timolol | Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye |
Ledipasvir with sofosbuvir | Tablet containing 90 mg ledipasvir with 400 mg sofosbuvir | Oral |
Leflunomide | Tablet 10 mg | Oral |
| Tablet 20 mg | Oral |
Lenvatinib | Capsule 10 mg (as mesilate) | Oral |
| Capsule 4 mg (as mesilate) | Oral |
Lercanidipine | Tablet containing lercanidipine hydrochloride 10 mg | Oral |
| Tablet containing lercanidipine hydrochloride 20 mg | Oral |
Lercanidipine with enalapril | Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 10 mg | Oral |
| Tablet containing lercanidipine hydrochloride 10 mg with enalapril maleate 20 mg | Oral |
Letrozole | Tablet 2.5 mg | Oral |
Leuprorelin | I.M. injection (3 month modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 22.5 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 30 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 45 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| I.M. injection (modified release), powder for injection containing leuprorelin acetate 7.5 mg with diluent in pre‑filled dual‑chamber syringe | Injection |
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 22.5 mg, injection set | Injection |
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 30 mg, injection set | Injection |
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 45 mg, injection set | Injection |
| Suspension for subcutaneous injection (modified release) containing leuprorelin acetate 7.5 mg, injection set | Injection |
Leuprorelin and bicalutamide | Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
| Pack containing 1 syringe containing leuprorelin 22.5 mg (as acetate) and 84 tablets bicalutamide 50 mg | Injection/oral |
| Pack containing 1 syringe containing leuprorelin 7.5 mg (as acetate) and 28 tablets bicalutamide 50 mg | Injection/oral |
Levetiracetam | Oral solution 100 mg per mL, 300 mL | Oral |
| Tablet 1 g | Oral |
| Tablet 250 mg | Oral |
| Tablet 500 mg | Oral |
Levodopa with benserazide | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) (sustained release) | Oral |
| Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
| Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral |
| Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral |
| Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral |
Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | Intra‑intestinal |
| Tablet (modified release) 200 mg‑50 mg (as monohydrate) | Oral |
| Tablet (prolonged release) 200 mg‑50 mg | Oral |
| Tablet 100 mg‑25 mg (as monohydrate) | Oral |
| Tablet 250 mg‑25 mg (as monohydrate) | Oral |
Levodopa with carbidopa and entacapone | Tablet 100 mg‑25 mg (as monohydrate)‑200 mg | Oral |
| Tablet 125 mg‑31.25 mg (as monohydrate)‑200 mg | Oral |
| Tablet 150 mg‑37.5 mg (as monohydrate)‑200 mg | Oral |
| Tablet 200 mg‑50 mg (as monohydrate)‑200 mg | Oral |
| Tablet 50 mg‑12.5 mg (as monohydrate)‑200 mg | Oral |
| Tablet 75 mg‑18.75 mg (as monohydrate)‑200 mg | Oral |
Levonorgestrel | Intrauterine drug delivery system 19.5 mg | Intrauterine |
| Intrauterine drug delivery system 52 mg | intrauterine |
| Tablets 30 micrograms, 28 | Oral |
Levonorgestrel with ethinylestradiol | Pack containing 21 tablets 100 micrograms‑20 micrograms and 7 inert tablets | Oral |
| Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets | Oral |
| Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets | Oral |
| Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets | Oral |
Levothyroxine | Tablet containing 100 micrograms anhydrous levothyroxine sodium | Oral |
| Tablet containing 200 micrograms anhydrous levothyroxine sodium | Oral |
| Tablet containing 50 micrograms anhydrous levothyroxine sodium | Oral |
| Tablet containing 75 micrograms anhydrous levothyroxine sodium | Oral |
Lidocaine | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | Injection |
Linagliptin | Tablet 5 mg | Oral |
Linagliptin with metformin | Tablet containing 2.5 mg linagliptin with 1000 mg metformin hydrochloride | Oral |
| Tablet containing 2.5 mg linagliptin with 500 mg metformin hydrochloride | Oral |
| Tablet containing 2.5 mg linagliptin with 850 mg metformin hydrochloride | Oral |
Lincomycin | Injection 600 mg (as hydrochloride monohydrate) in 2 mL | Injection |
Liothyronine | Tablet containing liothyronine sodium 20 micrograms | Oral |
Lisdexamfetamine | Capsule containing lisdexamfetamine dimesilate 20 mg | Oral |
| Capsule containing lisdexamfetamine dimesilate 30 mg | Oral |
| Capsule containing lisdexamfetamine dimesilate 40 mg | Oral |
| Capsule containing lisdexamfetamine dimesilate 50 mg | Oral |
| Capsule containing lisdexamfetamine dimesilate 60 mg | Oral |
| Capsule containing lisdexamfetamine dimesilate 70 mg | Oral |
Lisinopril | Tablet 10 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 5 mg | Oral |
Lithium | Tablet containing lithium carbonate 250 mg | Oral |
| Tablet containing lithium carbonate 450 mg (slow release) | Oral |
Loperamide | Capsule containing loperamide hydrochloride 2 mg | Oral |
Lorlatinib | Tablet 25 mg | Oral |
| Tablet 100 mg | Oral |
Losartan | Tablet containing losartan potassium 25 mg | Oral |
| Tablet containing losartan potassium 50 mg | Oral |
Lurasidone | Tablet containing lurasidone hydrochloride 40 mg | Oral |
| Tablet containing lurasidone hydrochloride 80 mg | Oral |
Macrogol 3350 | Oral liquid 13.125 g in 25 mL with electrolytes, 500 mL | Oral |
| Powder for oral solution 510 g | Oral |
| Sachets containing powder for oral solution 13.125 g with electrolytes, 30 | Oral |
Magnesium | Tablet 37.4 mg (as aspartate dihydrate) | Oral |
Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection |
| Tablet containing medroxyprogesterone acetate 10 mg | Oral |
| Tablet containing medroxyprogesterone acetate 100 mg | Oral |
| Tablet containing medroxyprogesterone acetate 200 mg | Oral |
| Tablet containing medroxyprogesterone acetate 250 mg | Oral |
| Tablet containing medroxyprogesterone acetate 5 mg | Oral |
| Tablet containing medroxyprogesterone acetate 500 mg | Oral |
Mefenamic acid | Capsule 250 mg | Oral |
Meloxicam | Capsule 15 mg | Oral |
| Capsule 7.5 mg | Oral |
| Tablet 15 mg | Oral |
| Tablet 7.5 mg | Oral |
Melphalan | Tablet 2 mg | Oral |
Memantine | Tablet containing memantine hydrochloride 10 mg | Oral |
| Tablet containing memantine hydrochloride 20 mg | Oral |
Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL | Oral |
| Tablet containing mercaptopurine monohydrate 50 mg | Oral |
Mesalazine | Enemas 1 g in 100 mL, 7 | Rectal |
| Enemas 2 g in 60 mL, 7 | Rectal |
| Enemas 4 g in 60 mL, 7 | Rectal |
| Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | Rectal |
| Sachet containing granules, 500 mg per sachet | Oral |
| Sachet containing granules, 1 g per sachet | Oral |
| Sachet containing granules, 1.5 g per sachet | Oral |
| Sachet containing granules, 3 g per sachet | Oral |
| Sachet containing prolonged release granules, 1 g per sachet | Oral |
| Sachet containing prolonged release granules, 2 g per sachet | Oral |
| Sachet containing prolonged release granules, 4 g per sachet | Oral |
| Suppository 1 g | Rectal |
| Suppository (moulded) 1 g | Rectal |
| Tablet 250 mg (enteric coated) | Oral |
| Tablet 500 mg (enteric coated) | Oral |
| Tablet 500 mg (prolonged release) | Oral |
| Tablet 800 mg (enteric coated) | Oral |
| Tablet 1 g (enteric coated) | Oral |
| Tablet 1 g (prolonged release) | Oral |
| Tablet 1.2 g (prolonged release) | Oral |
| Tablet 1.6 g (enteric coated) | Oral |
Mesna | Solution for I.V. injection 1 g in 10 mL ampoule | Injection |
| Solution for I.V. injection 400 mg in 4 mL ampoule | Injection |
Metformin | Tablet containing metformin hydrochloride 500 mg | Oral |
| Tablet containing metformin hydrochloride 850 mg | Oral |
| Tablet containing metformin hydrochloride 1 g | Oral |
| Tablet (extended release) containing metformin hydrochloride 500 mg | Oral |
| Tablet (extended release) containing metformin hydrochloride 1 g | Oral |
Methadone | Injection containing methadone hydrochloride 10 mg in 1 mL | Injection |
| Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL | Oral |
| Tablet containing methadone hydrochloride 10 mg | Oral |
Methenamine | Tablet containing methenamine hippurate 1 g | Oral |
Methotrexate | Injection 10 mg in 0.2 mL pre‑filled syringe | Injection |
| Injection 10 mg in 0.4 mL pre‑filled syringe | Injection |
| Injection 15 mg in 0.3 mL pre‑filled syringe | Injection |
| Injection 15 mg in 0.6 mL pre‑filled syringe | Injection |
| Injection 20 mg in 0.4 mL pre‑filled syringe | Injection |
| injection 20 mg in 0.8 mL pre‑filled syringe | Injection |
| Injection 25 mg in 0.5 mL pre‑filled syringe | Injection |
| Injection 25 mg in 1 mL pre‑filled syringe | Injection |
| Injection 5 mg in 2 mL vial | Injection |
| Injection 50 mg in 2 mL vial | Injection |
| Injection 7.5 mg in 0.15 mL pre‑filled syringe | Injection |
| Injection 7.5 mg in 0.3 mL pre‑filled syringe | Injection |
| Tablet 10 mg | Oral |
| Tablet 2.5 mg | Oral |
Methyldopa | Tablet 250 mg (as sesquihydrate) | Oral |
Methylnaltrexone | Solution for injection containing methylnaltrexone bromide 12 mg in 0.6 mL | Injection |
Methylphenidate | Capsule containing methylphenidate hydrochloride 10 mg (modified release) | Oral |
| Capsule containing methylphenidate hydrochloride 20 mg (modified release) | Oral |
| Capsule containing methylphenidate hydrochloride 30 mg (modified release) | Oral |
| Capsule containing methylphenidate hydrochloride 40 mg (modified release) | Oral |
| Capsule containing methylphenidate hydrochloride 60 mg (modified release) | Oral |
| Tablet containing methylphenidate hydrochloride 10 mg | Oral |
| Tablet containing methylphenidate hydrochloride 18 mg (extended release) | Oral |
| Tablet containing methylphenidate hydrochloride 27 mg (extended release) | Oral |
| Tablet containing methylphenidate hydrochloride 36 mg (extended release) | Oral |
| Tablet containing methylphenidate hydrochloride 54 mg (extended release) | Oral |
Methylprednisolone | Cream containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Fatty ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Injection containing methylprednisolone acetate 40 mg in 1 mL | Injection |
| Lotion containing methylprednisolone aceponate 1 mg per g, 20 g | Application |
| Ointment containing methylprednisolone aceponate 1 mg per g, 15 g | Application |
| Powder for injection 1 g (as sodium succinate) | Injection |
| Powder for injection 40 mg (as sodium succinate) | Injection |
| Powder for injection 40 mg (as sodium succinate) with diluent | Injection |
Metoclopramide | Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL | Injection |
| Tablet containing 10 mg metoclopramide hydrochloride (as monohydrate) | Oral |
Metoprolol | Tablet containing metoprolol tartrate 100 mg | Oral |
| Tablet containing metoprolol tartrate 50 mg | Oral |
Metoprolol succinate | Tablet 190 mg (controlled release) | Oral |
| Tablet 23.75 mg (controlled release) | Oral |
| Tablet 47.5 mg (controlled release) | Oral |
| Tablet 95 mg (controlled release) | Oral |
Metronidazole | Oral suspension containing metronidazole benzoate 320 mg per 5 mL, 100 mL | Oral |
| Suppositories 500 mg, 10 | Rectal |
| Tablet 200 mg | Oral |
| Tablet 400 mg | Oral |
Mianserin | Tablet containing mianserin hydrochloride 10 mg | Oral |
| Tablet containing mianserin hydrochloride 20 mg | Oral |
Miconazole | Cream containing miconazole nitrate 20 mg per g, 30 g | Application |
| Cream containing miconazole nitrate 20 mg per g, 70 g | Application |
| Powder containing miconazole nitrate 20 mg per g, 30 g | Application |
| Tincture 20 mg per mL, 30 mL | Application |
Mifepristone and misoprostol | Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms | Oral |
Milk powder ‑‑ synthetic | Low calcium oral powder 400 g (Locasol) | Oral |
Milk protein and fat formula with vitamins and minerals ‑‑ carbohydrate free | Oral powder 225 g (Carbohydrate Free Mixture) | Oral |
Minocycline | Tablet 50 mg (as hydrochloride) | Oral |
Minoxidil | Tablet 10 mg | Oral |
Mirtazapine | Tablet 15 mg | Oral |
| Tablet 15 mg (orally disintegrating) | Oral |
| Tablet 30 mg | Oral |
| Tablet 30 mg (orally disintegrating) | Oral |
| Tablet 45 mg | Oral |
| Tablet 45 mg (orally disintegrating) | Oral |
Moclobemide | Tablet 150 mg | Oral |
| Tablet 300 mg | Oral |
Modafinil | Tablet 100 mg | Oral |
Mometasone | Cream containing mometasone furoate 1 mg per g, 15 g | Application |
| Lotion containing mometasone furoate 1 mg per g, 30 mL | Application |
| Ointment containing mometasone furoate 1 mg per g, 15 g | Application |
Montelukast | Tablet, chewable, 4 mg (as sodium) | Oral |
| Tablet, chewable, 5 mg (as sodium) | Oral |
Morphine | Capsule containing morphine sulfate pentahydrate 10 mg (containing sustained release pellets) | Oral |
| Capsule containing morphine sulfate pentahydrate 100 mg (containing sustained release pellets) | Oral |
| Capsule containing morphine sulfate pentahydrate 120 mg (controlled release) | Oral |
| Capsule containing morphine sulfate pentahydrate 20 mg (containing sustained release pellets) | Oral |
| Capsule containing morphine sulfate pentahydrate 30 mg (controlled release) | Oral |
| Capsule containing morphine sulfate pentahydrate 50 mg (containing sustained release pellets) | Oral |
| Capsule containing morphine sulfate pentahydrate 60 mg (controlled release) | Oral |
| Capsule containing morphine sulfate pentahydrate 90 mg (controlled release) | Oral |
| Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL | Injection |
| Injection containing morphine hydrochloride trihydrate 100 mg in 5 mL | Injection |
| Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL | Injection |
| Injection containing morphine hydrochloride trihydrate 50 mg in 5 mL | Injection |
| Injection containing morphine sulfate pentahydrate 10 mg in 1 mL | Injection |
| Injection containing morphine sulfate pentahydrate 15 mg in 1 mL | Injection |
| Injection containing morphine sulfate pentahydrate 30 mg in 1 mL | Injection |
| Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 200 mL | Oral |
| Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 200 mL | Oral |
| Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 200 mL | Oral |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 100 mg per sachet | Oral |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 20 mg per sachet | Oral |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 200 mg per sachet | Oral |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 30 mg per sachet | Oral |
| Sachet containing controlled release granules for oral suspension, containing morphine sulfate pentahydrate 60 mg per sachet | Oral |
| Tablet containing morphine sulfate pentahydrate 10 mg | Oral |
| Tablet containing morphine sulfate pentahydrate 10 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 100 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 15 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 20 mg | Oral |
| Tablet containing morphine sulfate pentahydrate 200 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 30 mg | Oral |
| Tablet containing morphine sulfate pentahydrate 30 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 5 mg (controlled release) | Oral |
| Tablet containing morphine sulfate pentahydrate 60 mg (controlled release) | Oral |
Moxonidine | Tablet 200 micrograms | Oral |
| Tablet 400 micrograms | Oral |
Mupirocin | Nasal ointment 20 mg (as calcium) per g, 3 g | Nasal |
| Nasal ointment 20 mg (as calcium) per g, 5 g | Nasal |
Mycobacterium bovis (Bacillus Calmette and Guerin), Tice strain | Vial containing powder for intravesical administration approximately 5 x 10<sup>8</sup> CFU | Intravesical |
Mycophenolic acid | Capsule containing mycophenolate mofetil 250 mg | Oral |
| Powder for oral suspension containing mycophenolate mofetil 1 g per 5 mL, 165 mL | Oral |
| Tablet (enteric coated) containing mycophenolate sodium equivalent to 180 mg mycophenolic acid | Oral |
| Tablet (enteric coated) containing mycophenolate sodium equivalent to 360 mg mycophenolic acid | Oral |
| Tablet containing mycophenolate mofetil 500 mg | Oral |
Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | Nasal |
Naloxone | Injection containing naloxone hydrochloride 2 mg in 2 mL pre‑filled syringe | Injection |
| Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule | Injection |
| Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 | Nasal |
Naltrexone | Tablet containing naltrexone hydrochloride 50 mg | Oral |
Naproxen | Oral suspension 125 mg per 5 mL, 474 mL | Oral |
| Tablet 1 g (sustained release) | Oral |
| Tablet 250 mg | Oral |
| Tablet 750 mg (sustained release) | Oral |
| Tablet containing naproxen sodium 550 mg | Oral |
Naratriptan | Tablet 2.5 mg (as hydrochloride) | Oral |
Nebivolol | Tablet 1.25 mg (as hydrochloride) | Oral |
| Tablet 10 mg (as hydrochloride) | Oral |
| Tablet 5 mg (as hydrochloride) | Oral |
Netupitant with Palonosetron | Capsule containing netupitant 300 mg with palonosetron 500 microgram (as hydrochloride) | Oral |
Nicorandil | Tablets 10 mg, 60 | Oral |
| Tablets 20 mg, 60 | Oral |
Nicotine | Gum 2 mg | Buccal |
| Gum 4 mg | Buccal |
| Lozenge 2 mg | Buccal |
| Lozenge 4 mg | Buccal |
| Transdermal patch 114 mg | Transdermal |
| Transdermal patch 17.5 mg | Transdermal |
| Transdermal patch 35 mg | Transdermal |
| Transdermal patch 39.4 mg | Transdermal |
| Transdermal patch 52.5 mg | Transdermal |
Nifedipine | Tablet 10 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 30 mg (controlled release) | Oral |
| Tablet 60 mg (controlled release) | Oral |
Nilotinib | Capsule 150 mg (as hydrochloride monohydrate) | Oral |
| Capsule 200 mg (as hydrochloride monohydrate) | Oral |
Nintedanib | Capsule 100 mg | Oral |
| Capsule 150 mg | Oral |
Nitrazepam | Tablet 5 mg | Oral |
Nitrofurantoin | Capsule 50 mg | Oral |
| Capsule 50 mg, USP | Oral |
| Capsule 100 mg | Oral |
Nizatidine | Capsule 150 mg | Oral |
| Capsule 300 mg | Oral |
Norethisterone | Tablet 5 mg | Oral |
| Tablets 350 micrograms, 28 | Oral |
Norethisterone with ethinylestradiol | Pack containing 21 tablets 1 mg‑35 micrograms and 7 inert tablets | Oral |
| Pack containing 21 tablets 500 micrograms‑35 micrograms and 7 inert tablets | Oral |
Norethisterone with mestranol | Pack containing 21 tablets 1 mg‑50 micrograms and 7 inert tablets | Oral |
Norfloxacin | Tablet 400 mg | Oral |
Nortriptyline | Tablet 10 mg (as hydrochloride) | Oral |
| Tablet 25 mg (as hydrochloride) | Oral |
Nystatin | Capsule 500,000 units | Oral |
| Tablet 500,000 units | Oral |
Obeticholic acid | Tablet 5 mg | Oral |
| Tablet 10 mg | Oral |
Ocriplasmin | Solution for intravitreal injection 0.375 mg in 0.3 mL | Injection |
Ofatumumab | Solution for injection 20 mg in 0.4 mL pre-filled pen | Injection |
Ofloxacin | Eye drops 3 mg per mL, 5 mL | Application to the eye |
Olanzapine | Powder for injection 210 mg (as pamoate monohydrate) with diluent | Injection |
| Powder for injection 300 mg (as pamoate monohydrate) with diluent | Injection |
| Powder for injection 405 mg (as pamoate monohydrate) with diluent | Injection |
| Tablet 10 mg | Oral |
| Tablet 10 mg (orally disintegrating) | Oral |
| Tablet 15 mg (orally disintegrating) | Oral |
| Tablet 2.5 mg | Oral |
| Tablet 20 mg (orally disintegrating) | Oral |
| Tablet 5 mg | Oral |
| Tablet 5 mg (orally disintegrating) | Oral |
| Tablet 7.5 mg | Oral |
| Wafer 10 mg | Oral |
| Wafer 15 mg | Oral |
| Wafer 20 mg | Oral |
| Wafer 5 mg | Oral |
Olaparib | Tablet 100 mg | Oral |
| Tablet 150 mg | Oral |
Olmesartan | Tablet containing olmesartan medoxomil 20 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg | Oral |
Olmesartan with amlodipine | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) | Oral |
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral |
Olmesartan with hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 12.5 mg | Oral |
| Tablet containing olmesartan medoxomil 40 mg with hydrochlorothiazide 25 mg | Oral |
Olsalazine | Capsule containing olsalazine sodium 250 mg | Oral |
| Tablet containing olsalazine sodium 500 mg | Oral |
Omeprazole | Capsule 20 mg | Oral |
| Tablet 10 mg (as magnesium) | Oral |
| Tablet 20 mg | Oral |
| Tablet 20 mg (as magnesium) | Oral |
Ondansetron | Syrup 4 mg (as hydrochloride dihydrate) per 5 mL, 50 mL | Oral |
| Tablet (orally disintegrating) 4 mg | Oral |
| Tablet (orally disintegrating) 8 mg | Oral |
| Tablet 4 mg (as hydrochloride dihydrate) | Oral |
| Tablet 8 mg (as hydrochloride dihydrate) | Oral |
| Wafer 4 mg | Oral |
| Wafer 8 mg | Oral |
Osimertinib | Tablet 40 mg | Oral |
| Tablet 80 mg | Oral |
Oxazepam | Tablet 15 mg | Oral |
| Tablet 30 mg | Oral |
Oxcarbazepine | Oral suspension 60 mg per mL, 250 mL | Oral |
| Tablet 150 mg | Oral |
| Tablet 300 mg | Oral |
| Tablet 600 mg | Oral |
Oxprenolol | Tablet containing oxprenolol hydrochloride 40 mg | Oral |
Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral |
| Transdermal patches 36 mg, 8 | Transdermal |
Oxycodone | Capsule containing oxycodone hydrochloride 10 mg | Oral |
| Capsule containing oxycodone hydrochloride 20 mg | Oral |
| Capsule containing oxycodone hydrochloride 5 mg | Oral |
| Oral solution containing oxycodone hydrochloride 1 mg per mL, 250 mL | Oral |
| Suppository 30 mg (as pectinate) | Rectal |
| Tablet containing oxycodone hydrochloride 10 mg (controlled release) | Oral |
| Tablet containing oxycodone hydrochloride 15 mg (controlled release) | Oral |
| Tablet containing oxycodone hydrochloride 20 mg (controlled release) | Oral |
| Tablet containing oxycodone hydrochloride 30 mg (controlled release) | Oral |
| Tablet containing oxycodone hydrochloride 40 mg (controlled release) | Oral |
| Tablet containing oxycodone hydrochloride 5 mg | Oral |
| Tablet containing oxycodone hydrochloride 80 mg (controlled release) | Oral |
Oxycodone with naloxone | Tablet (controlled release) containing oxycodone hydrochloride 10 mg with naloxone hydrochloride 5 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 15 mg with naloxone hydrochloride 7.5 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 2.5 mg with naloxone hydrochloride 1.25 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 20 mg with naloxone hydrochloride 10 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 30 mg with naloxone hydrochloride 15 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 40 mg with naloxone hydrochloride 20 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 5 mg with naloxone hydrochloride 2.5 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 60 mg with naloxone hydrochloride 30 mg | Oral |
| Tablet (controlled release) containing oxycodone hydrochloride 80 mg with naloxone hydrochloride 40 mg | Oral |
Ozanimod | Capsule 920 micrograms | Oral |
| Pack containing 4 capsules 230 micrograms and 3 capsules 460 micrograms | Oral |
Palbociclib | Capsule 100 mg | Oral |
| Capsule 125 mg | Oral |
| Capsule 75 mg | Oral |
Paliperidone | I.M. injection (modified release) 100 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 150 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 175 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 25 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 263 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 350 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 50 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 525 mg (as palmitate) in pre‑filled syringe | Injection |
| I.M. injection (modified release) 75 mg (as palmitate) in pre‑filled syringe | Injection |
| Tablet 3 mg (prolonged release) | Oral |
| Tablet 6 mg (prolonged release) | Oral |
| Tablet 9 mg (prolonged release) | Oral |
Palonosetron | Injection 250 micrograms (as hydrochloride) in 5 mL | Injection |
Pamidronic acid | Concentrated injection containing pamidronate disodium 15 mg in 5 mL | Injection |
| Concentrated injection containing pamidronate disodium 30 mg in 10 mL | Injection |
| Concentrated injection containing pamidronate disodium 60 mg in 10 mL | Injection |
Pancreatic extract | Capsule (containing enteric coated minimicrospheres) providing not less than 10,000 BP units of lipase activity | Oral |
| Capsule (containing enteric coated minimicrospheres) providing not less than 25,000 BP units of lipase activity | Oral |
| Capsule (containing enteric coated minimicrospheres) providing not less than 35,000 BP units of lipase activity | Oral |
| Capsule (containing enteric coated minimicrospheres) providing not less than 40,000 BP units of lipase activity | Oral |
| Granules (enteric coated) providing not less than 5,000 BP units of lipase activity per 100 mg, 20 g | Oral |
Pancrelipase | Capsule (containing enteric coated microtablets) providing not less than 25,000 BP units of lipase activity | Oral |
Pantoprazole | Sachet containing granules 40 mg (as sodium sesquihydrate) | Oral |
| Tablet (enteric coated) 20 mg (as sodium sesquihydrate) | Oral |
| Tablet (enteric coated) 40 mg (as sodium sesquihydrate) | Oral |
Paracetamol | Oral liquid 120 mg per 5 mL, 100 mL | Oral |
| Oral liquid 240 mg per 5 mL, 200 mL | Oral |
| Suppository 500 mg | Rectal |
| Tablet 500 mg | Oral |
| Tablet 665 mg (modified release) | Oral |
Paraffin | Eye drops containing liquid paraffin, glycerol, tyloxapol, poloxamer-188, trometamol hydrochloride, trometamol, cetalkonium chloride, 10 mL (preservative free) | Application to the eye |
| Eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye |
| Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g | Application to the eye |
Paraffin with retinol palmitate | Eye ointment, compound, containing liquid paraffin, light liquid paraffin, wool fat, white soft paraffin and retinol palmitate, 5 g | Application to the eye |
Paroxetine | Tablet 20 mg (as hydrochloride) | Oral |
Pazopanib | Tablet 200 mg (as hydrochloride) | Oral |
| Tablet 400 mg (as hydrochloride) | Oral |
Peginterferon alfa‑2a | Injection 135 micrograms in 0.5 mL single use pre‑filled syringe | Injection |
| Injection 180 micrograms in 0.5 mL single use pre‑filled syringe | Injection |
Peginterferon beta‑1a | Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL | Injection |
| Single use injection pen containing 125 micrograms in 0.5 mL | Injection |
Penicillamine | Tablet 125 mg | Oral |
| Tablet 250 mg | Oral |
Perampanel | Tablet 10 mg (as hemisesquihydrate) | Oral |
| Tablet 12 mg (as hemisesquihydrate) | Oral |
| Tablet 2 mg (as hemisesquihydrate) | Oral |
| Tablet 4 mg (as hemisesquihydrate) | Oral |
| Tablet 6 mg (as hemisesquihydrate) | Oral |
| Tablet 8 mg (as hemisesquihydrate) | Oral |
Perfluorohexyloctane | Eye drops, 3 mL | Application to the eye |
Perhexiline | Tablet containing perhexiline maleate 100 mg | Oral |
Periciazine | Tablet 10 mg | Oral |
| Tablet 2.5 mg | Oral |
Perindopril | Tablet containing perindopril arginine 10 mg | Oral |
| Tablet containing perindopril arginine 2.5 mg | Oral |
| Tablet containing perindopril arginine 5 mg | Oral |
| Tablet containing perindopril erbumine 2 mg | Oral |
| Tablet containing perindopril erbumine 4 mg | Oral |
| Tablet containing perindopril erbumine 8 mg | Oral |
Perindopril with amlodipine | Tablet containing 10 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral |
| Tablet containing 10 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral |
| Tablet containing 5 mg perindopril arginine with 10 mg amlodipine (as besilate) | Oral |
| Tablet containing 5 mg perindopril arginine with 5 mg amlodipine (as besilate) | Oral |
Perindopril with indapamide | Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg | Oral |
| Tablet containing perindopril arginine 5 mg with indapamide hemihydrate 1.25 mg | Oral |
| Tablet containing perindopril erbumine 4 mg with indapamide hemihydrate 1.25 mg | Oral |
Permethrin | Cream 50 mg per g, 30 g | Application |
Phenelzine | Tablet 15 mg (as sulfate) | Oral |
| Tablet 15 mg (as sulfate) (USP) | Oral |
Phenobarbital | Injection 200 mg (as sodium) in 1 mL | Injection |
| Tablet 30 mg | Oral |
Phenoxybenzamine | Capsule containing phenoxybenzamine hydrochloride 10 mg | Oral |
| Capsules containing phenoxybenzamine hydrochloride 10 mg, 30 | Oral |
Phenoxymethylpenicillin | Capsule 250 mg phenoxymethylpenicillin (as potassium) | Oral |
| Capsule 500 mg phenoxymethylpenicillin (as potassium) | Oral |
| Oral suspension 150 mg (as benzathine) per 5 mL, 100 mL | Oral |
| Powder for oral liquid 125 mg (as potassium) per 5 mL, 100 mL | Oral |
| Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL | Oral |
| Tablet 250 mg phenoxymethylpenicillin (as potassium) | Oral |
| Tablet 500 mg phenoxymethylpenicillin (as potassium) | Oral |
Phenylalanine with carbohydrate | Sachets of oral powder 4 g containing 50 mg phenylalanine, 30 (Phenylalanine 50) | Oral |
Phenytoin | Capsule containing phenytoin sodium 100 mg | Oral |
| Capsule containing phenytoin sodium 30 mg | Oral |
| Oral suspension 30 mg per 5 mL, 500 mL | Oral |
| Tablet 50 mg | Oral |
Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL | Application to the eye |
| Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL | Application to the eye |
| Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL | Application to the eye |
Pimecrolimus | Cream 10 mg per g, 15 g | Application |
Pindolol | Tablet 5 mg | Oral |
Pioglitazone | Tablet 15 mg (as hydrochloride) | Oral |
| Tablet 30 mg (as hydrochloride) | Oral |
| Tablet 45 mg (as hydrochloride) | Oral |
Pirfenidone | Capsule 267 mg | Oral |
| Tablet 267 mg | Oral |
| Tablet 801mg | Oral |
Piroxicam | Capsule 10 mg | Oral |
| Capsule 20 mg | Oral |
| Dispersible tablet 10 mg | Oral |
| Dispersible tablet 20 mg | Oral |
Pizotifen | Tablet 500 micrograms (as malate) | Oral |
Polyethylene glycol 400 with propylene glycol | Eye drops 4 mg‑3 mg per mL, 15 mL | Application to the eye |
| Eye drops 4 mg‑3 mg per mL, single dose units 0.8 mL, 28 | Application to the eye |
Poly‑l‑lactic acid | Powder for injection 150 mg | Injection |
Polyvinyl alcohol | Eye drops 14 mg per mL, 15 mL | Application to the eye |
Ponatinib | Tablet 15 mg (as hydrochloride) | Oral |
| Tablet 45 mg (as hydrochloride) | Oral |
Posaconazole | Tablet (modified release) 100 mg | Oral |
Potassium chloride | Tablet 600 mg (sustained release) | Oral |
Potassium chloride with potassium bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | Oral |
Pramipexole | Tablet (extended release) containing pramipexole dihydrochloride monohydrate 1.5 mg | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 2.25 mg | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3 mg | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 3.75 mg | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 375 micrograms | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 4.5 mg | Oral |
| Tablet (extended release) containing pramipexole dihydrochloride monohydrate 750 micrograms | Oral |
| Tablet containing pramipexole dihydrochloride monohydrate 1 mg | Oral |
| Tablet containing pramipexole dihydrochloride monohydrate 125 micrograms | Oral |
| Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms | Oral |
Pravastatin | Tablet containing pravastatin sodium 10 mg | Oral |
| Tablet containing pravastatin sodium 20 mg | Oral |
| Tablet containing pravastatin sodium 40 mg | Oral |
| Tablet containing pravastatin sodium 80 mg | Oral |
Praziquantel | Tablet 600 mg | Oral |
Prazosin | Tablet 1 mg (as hydrochloride) | Oral |
| Tablet 2 mg (as hydrochloride) | Oral |
| Tablet 5 mg (as hydrochloride) | Oral |
Prednisolone | Enema, retention, 20 mg (as sodium phosphate) in 100 mL | Rectal |
| Oral solution 5 mg (as sodium phosphate) per mL, 30 mL | Oral |
| Suppositories 5 mg (as sodium phosphate), 10 | Rectal |
| Tablet 1 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 5 mg | Oral |
Prednisolone acetate | Eye drops containing prednisolone acetate 10 mg per mL, 10 mL | Application to the eye |
Prednisolone with phenylephrine | Eye drops containing prednisolone acetate 10 mg with phenylephrine hydrochloride 1.2 mg per mL, 10 mL | Application to the eye |
Prednisone | Tablet 1 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 5 mg | Oral |
Pregabalin | Capsule 150 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 300 mg | Oral |
| Capsule 75 mg | Oral |
Primidone | Tablet 250 mg | Oral |
| Tablet 250 mg (USP) | Oral |
Probenecid | Tablet 500 mg | Oral |
Procaine benzylpenicillin | Injection 1.5 g in disposable syringe | Injection |
Prochlorperazine | Injection containing prochlorperazine mesilate 12.5 mg in 1 mL | Injection |
| Tablet containing prochlorperazine maleate 5 mg | Oral |
Progesterone | Capsule 200 mg | Vaginal |
| Pessary 200 mg | Vaginal |
Promethazine | Injection containing promethazine hydrochloride 50 mg in 2 mL | Injection |
Propantheline | Tablet containing propantheline bromide 15 mg | Oral |
Propranolol | Tablet containing propranolol hydrochloride 10 mg | Oral |
| Tablet containing propranolol hydrochloride 160 mg | Oral |
| Tablet containing propranolol hydrochloride 40 mg | Oral |
Propylthiouracil | Tablet 50 mg | Oral |
Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docosahexaenoic acid | Oral liquid 130 mL, 30 (PKU Easy) | Oral |
Protein formula with carbohydrate, fat, vitamins and minerals | Oral liquid 500 mL, 12 (Nutrini Peptisorb Energy) | Oral |
Protein formula with vitamins and minerals, and low in potassium, phosphorus, calcium, chloride and vitamin A | Oral liquid 125 mL, 24 (Renastep) | Oral |
Protein hydrolysate formula with medium chain triglycerides | Oral powder 400 g (Alfaré) | Oral |
| Oral powder 450 g (Aptamil Gold+ Pepti‑Junior) | Oral |
Pyrantel | Tablet 125 mg (as embonate) | Oral |
| Tablet 250 mg (as embonate) | Oral |
Pyridostigmine | Tablet containing pyridostigmine bromide 10 mg | Oral |
| Tablet containing pyridostigmine bromide 180 mg (modified release) | Oral |
| Tablet containing pyridostigmine bromide 60 mg | Oral |
Quetiapine | Tablet (modified release) 150 mg (as fumarate) | Oral |
| Tablet (modified release) 200 mg (as fumarate) | Oral |
| Tablet (modified release) 300 mg (as fumarate) | Oral |
| Tablet (modified release) 400 mg (as fumarate) | Oral |
| Tablet (modified release) 50 mg (as fumarate) | Oral |
| Tablet 100 mg (as fumarate) | Oral |
| Tablet 200 mg (as fumarate) | Oral |
| Tablet 25 mg (as fumarate) | Oral |
| Tablet 300 mg (as fumarate) | Oral |
Quinagolide | Tablet 75 micrograms (as hydrochloride) | Oral |
Quinapril | Tablet 10 mg (as hydrochloride) | Oral |
| Tablet 20 mg (as hydrochloride) | Oral |
| Tablet 5 mg (as hydrochloride) | Oral |
Quinapril with hydrochlorothiazide | Tablet 10 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | Oral |
| Tablet 20 mg quinapril (as hydrochloride) with 12.5 mg hydrochlorothiazide | Oral |
Quinine | Tablet containing quinine sulfate dihydrate 300 mg | Oral |
Rabeprazole | Tablet containing rabeprazole sodium 10 mg (enteric coated) | Oral |
| Tablet containing rabeprazole sodium 20 mg (enteric coated) | Oral |
Raloxifene | Tablet containing raloxifene hydrochloride 60 mg | Oral |
Ramipril | Capsule 1.25 mg | Oral |
| Capsule 10 mg | Oral |
| Capsule 2.5 mg | Oral |
| Capsule 5 mg | Oral |
| Tablet 1.25 mg | Oral |
| Tablet 10 mg | Oral |
| Tablet 2.5 mg | Oral |
| Tablet 5 mg | Oral |
Ramipril with felodipine | Tablet 2.5 mg‑2.5 mg (modified release) | Oral |
| Tablet 5 mg‑5 mg (modified release) | Oral |
Ranibizumab | Solution for intravitreal injection 1.65 mg in 0.165 mL pre‑filled syringe | Injection |
| Solution for intravitreal injection 2.3 mg in 0.23 mL | Injection |
Ranitidine | Syrup 150 mg (as hydrochloride) per 10 mL, 300 mL | Oral |
| Tablet 150 mg (as hydrochloride) | Oral |
| Tablet 300 mg (as hydrochloride) | Oral |
Rasagiline | Tablet 1 mg (as mesilate) | Oral |
Reboxetine | Tablet 4 mg (as mesilate) | Oral |
Reteplase | Pack containing 2 vials powder for injection 10 units, 2 single use pre‑filled syringes with solvent, 2 reconstitution spikes and 2 needles | Injection |
Ribavirin | Tablet 400 mg | Oral |
| Tablet 600 mg | Oral |
Ribociclib | Tablet 200 mg | Oral |
Rifampicin | Capsule 150 mg | Oral |
| Capsule 300 mg | Oral |
| Syrup 100 mg per 5 mL, 60 mL | Oral |
Rifaximin | Tablet 550 mg | Oral |
Riluzole | Oral suspension 50 mg per 10 mL, 300 mL | Oral |
| Tablet 50 mg | Oral |
Risankizumab | Injection 75 mg in 0.83 mL pre‑filled syringe | Injection |
Risedronic acid | Tablet (enteric coated) containing risedronate sodium 35 mg | Oral |
| Tablet containing risedronate sodium 150 mg | Oral |
| Tablet containing risedronate sodium 30 mg | Oral |
| Tablet containing risedronate sodium 35 mg | Oral |
| Tablet containing risedronate sodium 5 mg | Oral |
Risedronic acid and calcium | Pack containing 4 tablets risedronate sodium 35 mg and 24 tablets calcium 500 mg (as carbonate) | Oral |
Risperidone | I.M. injection (modified release), set containing 1 vial powder for injection 25 mg and 1 pre‑filled syringe diluent 2 mL | Injection |
| I.M. injection (modified release), set containing 1 vial powder for injection 37.5 mg and 1 pre‑filled syringe diluent 2 mL | Injection |
| I.M. injection (modified release), set containing 1 vial powder for injection 50 mg and 1 pre‑filled syringe diluent 2 mL | Injection |
| Oral solution 1 mg per mL, 100 mL | Oral |
| Tablet 0.5 mg | Oral |
| Tablet 1 mg | Oral |
| Tablet 2 mg | Oral |
| Tablet 3 mg | Oral |
| Tablet 4 mg | Oral |
Rivaroxaban | Tablet 2.5 mg | Oral |
| Tablet 10 mg | Oral |
| Tablet 15 mg | Oral |
| Tablet 20 mg | Oral |
Rivastigmine | Capsule 1.5 mg (as hydrogen tartrate) | Oral |
| Capsule 3 mg (as hydrogen tartrate) | Oral |
| Capsule 4.5 mg (as hydrogen tartrate) | Oral |
| Capsule 6 mg (as hydrogen tartrate) | Oral |
| Transdermal patch 18 mg | Transdermal |
| Transdermal patch 27 mg | Transdermal |
| Transdermal patch 9 mg | Transdermal |
Rizatriptan | Tablet (orally disintegrating) 10 mg (as benzoate) | Oral |
| Wafer 10 mg (as benzoate) | Oral |
Romosozumab | Injection 105 mg in 1.17 mL single use pre-filled syringe | Injection |
Rosuvastatin | Tablet 10 mg (as calcium) | Oral |
| Tablet 20 mg (as calcium) | Oral |
| Tablet 40 mg (as calcium) | Oral |
| Tablet 5 mg (as calcium) | Oral |
Rotigotine | Transdermal patch 13.5 mg | Transdermal |
| Transdermal patch 18 mg | Transdermal |
| Transdermal patch 4.5 mg | Transdermal |
| Transdermal patch 9 mg | Transdermal |
Roxithromycin | Tablet 150 mg | Oral |
| Tablet 300 mg | Oral |
| Tablet for oral suspension 50 mg | Oral |
Ruxolitinib | Tablet 10 mg | Oral |
| Tablet 15 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 5 mg | Oral |
Sacubitril with valsartan | Tablet containing sacubitril 24.3 mg with valsartan 25.7 mg | Oral |
| Tablet containing sacubitril 48.6 mg with valsartan 51.4 mg | Oral |
| Tablet containing sacubitril 97.2 mg with valsartan 102.8 mg | Oral |
Safinamide | Tablet 100 mg | Oral |
| Tablet 50 mg | Oral |
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation |
| Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation |
| Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 | Inhalation |
| Oral solution 2 mg (as sulfate) per 5 mL, 150 mL | Oral |
| Pressurised inhalation in breath actuated device 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC‑free formulation) | Inhalation by mouth |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) | Inhalation by mouth |
Salmeterol | Powder for oral inhalation in breath actuated device 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth |
Sapropterin | Powder for oral solution 500 mg (as dihydrochloride) | Oral |
| Tablet (soluble) containing sapropterin dihydrochloride 100 mg | Oral |
Saxagliptin | Tablet 2.5 mg (as hydrochloride) | Oral |
| Tablet 5 mg (as hydrochloride) | Oral |
Saxagliptin with dapagliflozin | Tablet containing saxagliptin 5 mg with dapaglifozin 10 mg | Oral |
Saxagliptin with metformin | Tablet (modified release) containing 2.5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride | Oral |
| Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 1000 mg metformin hydrochloride | Oral |
| Tablet (modified release) containing 5 mg saxagliptin (as hydrochloride) with 500 mg metformin hydrochloride | Oral |
Secukinumab | Injection 150 mg in 1 mL pre‑filled pen | Injection |
Selegiline | Tablet containing selegiline hydrochloride 5 mg | Oral |
Semaglutide | Solution for injection 2 mg in 1.5 mL pre‑filled pen | Injection |
| Solution for injection 4 mg in 3 mL pre‑filled pen | Injection |
Sertraline | Tablet 50 mg (as hydrochloride) | Oral |
| Tablet 100 mg (as hydrochloride) | Oral |
Sevelamer | Tablet containing sevelamer carbonate 800 mg | Oral |
| Tablet containing sevelamer hydrochloride 800 mg | Oral |
Silver sulfadiazine | Cream 10 mg per g, 50 g | Application |
Simvastatin | Tablet 10 mg | Oral |
| Tablet 20 mg | Oral |
| Tablet 40 mg | Oral |
| Tablet 5 mg | Oral |
| Tablet 80 mg | Oral |
Siponimod | Tablet 250 micrograms (as hemifumarate) | Oral |
| Tablet 2 mg (as hemifumarate) | Oral |
Sirolimus | Oral solution 1 mg per mL, 60 mL | Oral |
| Tablet 0.5 mg | Oral |
| Tablet 1 mg | Oral |
| Tablet 2 mg | Oral |
Sitagliptin | Tablet 100 mg (as phosphate monohydrate) | Oral |
| Tablet 25 mg (as phosphate monohydrate) | Oral |
| Tablet 50 mg (as phosphate monohydrate) | Oral |
Sitagliptin with metformin | Tablet (modified release) containing 100 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Tablet (modified release) containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | Oral |
| Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 500 mg metformin hydrochloride | Oral |
| Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 850 mg metformin hydrochloride | Oral |
Sodium acid phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral |
Sodium bicarbonate | Capsule 840 mg | Oral |
Sodium phenylbutyrate | Granules 483 mg per g, 174 g | Oral |
Sofosbuvir with velpatasvir | Tablet containing 400 mg sofosbuvir with 100 mg velpatasvir | Oral |
Sofosbuvir with velpatasvir and voxilaprevir | Tablet containing 400 mg sofosbuvir with 100 mg velpatasvir and 100 mg voxilaprevir | Oral |
Sonidegib | Capsule 200 mg | Oral |
Sorafenib | Tablet 200 mg (as tosilate) | Oral |
Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate | Enemas 3.125 g‑450 mg‑45 mg in 5 mL, 12 | Rectal |
Sotalol | Tablet containing sotalol hydrochloride 160 mg | Oral |
| Tablet containing sotalol hydrochloride 80 mg | Oral |
Soy lecithin | Eye spray 10 mg per mL, 10 mL | Application |
Soy protein and fat formula with vitamins and minerals ‑‑ carbohydrate free | Oral liquid 384 mL (RCF) | Oral |
Spironolactone | Tablet 100 mg | Oral |
| Tablet 25 mg | Oral |
Sterculia with frangula bark | Granules 620 mg‑80 mg per g, 500 g | Oral |
Stiripentol | Capsule 250 mg | Oral |
| Capsule 500 mg | Oral |
| Powder for oral suspension 250 mg | Oral |
| Powder for oral suspension 500 mg | Oral |
Sucroferric oxyhydroxide | Tablet, chewable, 2.5 g (equivalent to 500 mg iron) | Oral |
Sulfasalazine | Tablet 500 mg | Oral |
| Tablet 500 mg (enteric coated) | Oral |
Sulthiame | Tablet 200 mg | Oral |
| Tablet 50 mg | Oral |
Sumatriptan | Nasal spray 20 mg in 0.1 mL single dose unit | Nasal |
| Tablet (fast disintegrating) 50 mg (as succinate) | Oral |
| Tablet 50 mg (as succinate) | Oral |
Sunitinib | Capsule 12.5 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 37.5 mg | Oral |
| Capsule 50 mg | Oral |
Tacrolimus | Capsule 0.5 mg | Oral |
| Capsule 0.5 mg (once daily prolonged release) | Oral |
| Capsule 0.75 mg | Oral |
| Capsule 1 mg | Oral |
| Capsule 1 mg (once daily prolonged release) | Oral |
| Capsule 2 mg | Oral |
| Capsule 3 mg (once daily prolonged release) | Oral |
| Capsule 5 mg | Oral |
| Capsule 5 mg (once daily prolonged release) | Oral |
Tafluprost | Eye drops 15 micrograms per mL, single dose units 0.3 mL, 30 | Application to the eye |
Tamoxifen | Tablet 20 mg (as citrate) | Oral |
Tapentadol | Tablet (modified release) 100 mg (as hydrochloride) | Oral |
| Tablet (modified release) 150 mg (as hydrochloride) | Oral |
| Tablet (modified release) 200 mg (as hydrochloride) | Oral |
| Tablet (modified release) 250 mg (as hydrochloride) | Oral |
| Tablet (modified release) 50 mg (as hydrochloride) | Oral |
Telmisartan | Tablet 40 mg | Oral |
| Tablet 80 mg | Oral |
Telmisartan with amlodipine | Tablet 40 mg‑10 mg (as besilate) | Oral |
| Tablet 40 mg‑5 mg (as besilate) | Oral |
| Tablet 80 mg‑10 mg (as besilate) | Oral |
| Tablet 80 mg‑5 mg (as besilate) | Oral |
Telmisartan with hydrochlorothiazide | Tablet 40 mg‑12.5 mg | Oral |
| Tablet 80 mg‑12.5 mg | Oral |
| Tablet 80 mg‑25 mg | Oral |
Temazepam | Tablet 10 mg | Oral |
Temozolomide | Capsule 100 mg | Oral |
| Capsule 140 mg | Oral |
| Capsule 180 mg | Oral |
| Capsule 20 mg | Oral |
| Capsule 250 mg | Oral |
| Capsule 5 mg | Oral |
Tenecteplase | Powder for injection 40 mg with solvent | Injection |
| Powder for injection 50 mg with solvent | Injection |
Tenofovir with emtricitabine | Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg | Oral |
| Tablet containing tenofovir disoproxil maleate 300 mg with emtricitabine 200 mg | Oral |
| Tablet containing tenofovir disoproxil phosphate 291 mg with emtricitabine 200 mg | Oral |
| Tablet containing tenofovir disoproxil succinate 301 mg with emtricitabine 200 mg | Oral |
Terbinafine | Cream containing terbinafine hydrochloride 10 mg per g, 15 g | Application |
| Tablet 250 mg (as hydrochloride) | Oral |
Terbutaline | Injection containing terbutaline sulfate 500 micrograms in 1 mL | Injection |
| Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 120 doses | Inhalation by mouth |
Teriflunomide | Tablet 14 mg | Oral |
Teriparatide | Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled cartridge | Injection |
| Injection 250 micrograms per mL, 2.4 mL in multi‑dose pre‑filled pen | Injection |
Testosterone | Capsule containing testosterone undecanoate 40 mg | Oral |
| I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | Injection |
| Transdermal cream 50 mg per mL, 50 mL | Transdermal |
| Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | Transdermal |
| Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | Transdermal |
| Transdermal gel 50 mg in 5 g sachet, 30 | Transdermal |
| Transdermal patches 24.3 mg, 30 | Transdermal |
Tetrabenazine | Tablet 25 mg | Oral |
Tetracosactide | Compound depot injection 1 mg in 1 mL | Injection |
Theophylline | Oral solution 133.3 mg per 25 mL, 500 mL | Oral |
| Tablet 200 mg (sustained release) | Oral |
| Tablet 250 mg (sustained release) | Oral |
| Tablet 300 mg (sustained release) | Oral |
Thiamine | Tablet containing thiamine hydrochloride 100 mg | Oral |
Thyrotropin alfa | Powder for injection 0.9 mg, 2 | Injection |
Tiagabine | Tablet 10 mg (as hydrochloride) | Oral |
| Tablet 15 mg (as hydrochloride) | Oral |
| Tablet 5 mg (as hydrochloride) | Oral |
Ticagrelor | Tablet 90 mg | Oral |
Tildrakizumab | Injection 100 mg in 1 mL single dose pre‑filled syringe | Injection |
Timolol | Eye drops (gellan gum solution) 5 mg (as maleate) per mL, 2.5 mL | Application to the eye |
| Eye drops 5 mg (as maleate) per mL, 5 mL | Application to the eye |
Tioguanine | Tablet 40 mg | Oral |
Tiotropium | Capsule containing powder for oral inhalation 13 micrograms (as bromide) (for use in Zonda device) | Inhalation by Mouth |
| Capsule containing powder for oral inhalation 18 micrograms (as bromide monohydrate) (for use in HandiHaler) | Inhalation by mouth |
| Solution for oral inhalation 2.5 micrograms (as bromide monohydrate) per actuation (60 actuations) | Inhalation by mouth |
Tiotropium with olodaterol | Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses | Inhalation by mouth |
Tirofiban | Solution concentrate for I.V. infusion 12.5 mg (as hydrochloride) in 50 mL | Injection |
Tobramycin | Capsule containing powder for oral inhalation 28 mg (for use in podhaler) | Inhalation by mouth |
| Eye drops 3 mg per mL, 5 mL | Application to the eye |
| Eye ointment 3 mg per g, 3.5 g | Application to the eye |
| Injection 500 mg (as sulfate) in 5 mL (without preservative) | Injection |
| Injection 80 mg (as sulfate) in 2 mL (without preservative) | Injection |
| Injection 80 mg in 2 mL | Injection |
| Solution for inhalation 300 mg in 5 mL | Inhalation |
Tocilizumab | Injection 162 mg in 0.9 mL single use pre‑filled pen | Injection |
| Injection 162 mg in 0.9 mL single use pre‑filled syringe | Injection |
Tofacitinib | Tablet 5 mg | Oral |
| Tablet 10 mg | Oral |
Tolvaptan | Pack containing 28 tablets 15 mg and 28 tablets 45 mg | Oral |
| Pack containing 28 tablets 30 mg and 28 tablets 60 mg | Oral |
| Pack containing 28 tablets 30 mg and 28 tablets 90 mg | Oral |
| Tablet 15 mg | Oral |
| Tablet 30 mg | Oral |
Topiramate | Capsule 15 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 50 mg | Oral |
| Tablet 100 mg | Oral |
| Tablet 200 mg | Oral |
| Tablet 25 mg | Oral |
| Tablet 50 mg | Oral |
Toremifene | Tablet 60 mg (as citrate) | Oral |
Tramadol | Capsule containing tramadol hydrochloride 50 mg | Oral |
| Injection containing tramadol hydrochloride 100 mg in 2 mL | Injection |
| Oral drops containing tramadol hydrochloride 100 mg per mL, 10 mL | Oral |
| Tablet (sustained release) containing tramadol hydrochloride 100 mg | Oral |
| Tablet (sustained release) containing tramadol hydrochloride 150 mg | Oral |
| Tablet (sustained release) containing tramadol hydrochloride 200 mg | Oral |
| Tablet (sustained release) containing tramadol hydrochloride 50 mg | Oral |
Trametinib | Tablet 2 mg | Oral |
| Tablet 500 micrograms | Oral |
Trandolapril | Capsule 1 mg | Oral |
| Capsule 2 mg | Oral |
| Capsule 4 mg | Oral |
| Capsule 500 micrograms | Oral |
Trandolapril with verapamil | Tablet containing trandolapril 2 mg with verapamil hydrochloride 180 mg (sustained release) | Oral |
| Tablet containing trandolapril 4 mg with verapamil hydrochloride 240 mg (sustained release) | Oral |
Tranexamic acid | Tablet 500 mg | Oral |
Tranylcypromine | Tablet 10 mg (as sulfate) | Oral |
Trastuzumab | Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL | Injection |
Travoprost | Eye drops 40 micrograms per mL, 2.5 mL | Application to the eye |
Travoprost with timolol | Eye drops 40 micrograms travoprost with timolol 5 mg (as maleate) per mL, 2.5 mL | Application to the eye |
Triamcinolone | Cream containing triamcinolone acetonide 200 micrograms per g, 100 g | Application |
| Injection containing triamcinolone acetonide 10 mg in 1 mL | Injection |
| Ointment containing triamcinolone acetonide 200 micrograms per g, 100 g | Application |
Triamcinolone with neomycin, gramicidin and nystatin | Ear drops containing triamcinolone acetonide 0.9 mg with neomycin 2.25 mg (as sulfate), gramicidin 225 micrograms and nystatin 90,000 units per mL, 7.5 mL | Application to the ear |
| Ear ointment containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 5 g | Application to the ear |
Trifluridine with tipiracil | Tablet containing 15 mg trifluridine with 6.14 mg tipiracil (as hydrochloride) | Oral |
| Tablet containing 20 mg trifluridine with 8.19 mg tipiracil (as hydrochloride) | Oral |
Triglycerides ‑ medium chain, formula | Oral liquid 500 mL, 8 (Nutrini Peptisorb) | Oral |
| Oral powder 400 g (Lipistart) | Oral |
| Oral powder 400 g (Monogen) | Oral |
| Oral powder 400 g (Peptamen Junior) | Oral |
| Sachets containing oral powder 16 g, 30 (MCT Pro‑Cal) | Oral |
Triglycerides, long chain with glucose polymer | Oral liquid 1 L, 6 (ProZero) | Oral |
| Oral liquid 200 mL, 27 (Sno‑Pro) | Oral |
| Oral liquid 250 mL, 18 (ProZero) | Oral |
Triglycerides, medium chain | Oil 500 mL (MCT Oil) | Oral |
| Oral emulsion 250 mL (Liquigen) | Oral |
| Oral liquid 225 mL, 15 (betaquik) | Oral |
Triglycerides, medium chain and long chain with glucose polymer | Oral powder 400 g (Duocal) | Oral |
Trihexyphenidyl | Tablet containing trihexyphenidyl hydrochloride 2 mg | Oral |
| Tablet containing trihexyphenidyl hydrochloride 5 mg | Oral |
Trimethoprim | Tablet 300 mg | Oral |
Trimethoprim with sulfamethoxazole | Paediatric oral suspension 40 mg‑200 mg per 5 mL, 100 mL | Oral |
| Tablet 160 mg‑800 mg | Oral |
Triptorelin | Powder for I.M. injection (prolonged release) 11.25 mg (as embonate) with solvent, syringe and needles | Injection |
| Powder for I.M. injection (prolonged release) 22.5 mg (as embonate) with solvent, syringe and needles | Injection |
| Powder for I.M. injection (prolonged release) 3.75 mg (as embonate) with solvent, syringe and needles | Injection |
Tropisetron | I.V. injection 5 mg (as hydrochloride) in 5 mL | Injection |
Tyrosine with carbohydrate | Sachets of oral powder 4 g containing 1 g tyrosine, 30 (Tyrosine 1000) | Oral |
Umeclidinium | Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses | Inhalation by mouth |
Umeclidinium with vilanterol | Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth |
Upadacitinib | Tablet 15 mg | Oral |
Ursodeoxycholic acid | Capsule 250 mg | Oral |
| Tablet 500 mg | Oral |
Ustekinumab | Injection 45 mg in 0.5 mL | Injection |
Valaciclovir | Tablet 500 mg (as hydrochloride) | Oral |
Valine with carbohydrate | Sachets of oral powder 4 g containing 1 g valine, 30 (Valine 1000) | Oral |
| Sachets of oral powder 4 g containing 50 mg valine, 30 (Valine 50) | Oral |
Valproic acid | Oral liquid containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
| Oral solution containing sodium valproate 200 mg per 5 mL, 300 mL | Oral |
| Tablet (enteric coated) containing sodium valproate 200 mg | Oral |
| Tablet (enteric coated) containing sodium valproate 500 mg | Oral |
| Tablet, crushable, containing sodium valproate 100 mg | Oral |
Valsartan | Tablet 160 mg | Oral |
| Tablet 320 mg | Oral |
| Tablet 40 mg | Oral |
| Tablet 80 mg | Oral |
Valsartan with hydrochlorothiazide | Tablet 160 mg‑12.5 mg | Oral |
| Tablet 160 mg‑25 mg | Oral |
| Tablet 320 mg‑12.5 mg | Oral |
| Tablet 320 mg‑25 mg | Oral |
| Tablet 80 mg‑12.5 mg | Oral |
Vancomycin | Capsule 125 mg (125,000 I.U.) (as hydrochloride) | Oral |
| Capsule 250 mg (250,000 I.U.) (as hydrochloride) | Oral |
| Powder for injection 1 g (1,000,000 I.U.) (as hydrochloride) | Injection |
| Powder for injection 500 mg (500,000 I.U.) (as hydrochloride) | Injection |
Varenicline | Box containing 11 tablets 0.5 mg (as tartrate) and 14 tablets 1 mg (as tartrate) in the first pack and 28 tablets 1 mg (as tartrate) in the second pack | Oral |
| Tablet 1 mg (as tartrate) | Oral |
Vedolizumab | Injection 108 mg in 0.68 mL single use pre-filled pen | Injection |
Vemurafenib | Tablet 240 mg | Oral |
Venetoclax | Pack containing 14 tablets venetoclax 10 mg and 7 tablets venetoclax 50 mg and 7 tablets venetoclax 100 mg and 14 tablets venetoclax 100 mg | Oral |
| Tablet 10 mg | Oral |
| Tablet 100 mg | Oral |
| Tablet 50 mg | Oral |
Venlafaxine | Capsule (modified release) 150 mg (as hydrochloride) | Oral |
| Capsule (modified release) 37.5 mg (as hydrochloride) | Oral |
| Capsule (modified release) 75 mg (as hydrochloride) | Oral |
Verapamil | Tablet containing verapamil hydrochloride 180 mg (sustained release) | Oral |
| Tablet containing verapamil hydrochloride 240 mg (sustained release) | Oral |
| Tablet containing verapamil hydrochloride 80 mg | Oral |
Vigabatrin | Oral powder, sachet 500 mg | Oral |
| Tablet 500 mg | Oral |
Vildagliptin | Tablet 50 mg | Oral |
Vildagliptin with metformin | Tablet containing 50 mg vildagliptin with 1000 mg metformin hydrochloride | Oral |
| Tablet containing 50 mg vildagliptin with 500 mg metformin hydrochloride | Oral |
| Tablet containing 50 mg vildagliptin with 850 mg metformin hydrochloride | Oral |
Vinorelbine | Capsule 20 mg (as tartrate) | Oral |
| Capsule 30 mg (as tartrate) | Oral |
Vismodegib | Capsule 150 mg | Oral |
Vitamins, minerals and trace elements formula | Sachets containing oral powder 7 g, 30 (Phlexy‑Vits) | Oral |
Vitamins, minerals and trace elements with carbohydrate | Oral powder 200 g (Paediatric Seravit) | Oral |
| Sachets containing oral powder 6 g, 30 (FruitiVits) | Oral |
Voriconazole | Powder for oral suspension 40 mg per mL, 70 mL | Oral |
| Tablet 200 mg | Oral |
| Tablet 50 mg | Oral |
Vorinostat | Capsule 100 mg | Oral |
Warfarin | Tablet containing warfarin sodium 1 mg | Oral |
| Tablet containing warfarin sodium 2 mg | Oral |
| Tablet containing warfarin sodium 3 mg | Oral |
| Tablet containing warfarin sodium 5 mg | Oral |
Whey protein formula supplemented with amino acids, long chain polyunsaturated fatty acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose | Oral powder 400 g, 6 (Renastart) | Oral |
Whey protein formula supplemented with amino acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose | Oral powder 400 g (Kindergen) | Oral |
Ziprasidone | Capsule 20 mg (as hydrochloride) | Oral |
| Capsule 40 mg (as hydrochloride) | Oral |
| Capsule 60 mg (as hydrochloride) | Oral |
| Capsule 80 mg (as hydrochloride) | Oral |
Zoledronic acid | Solution for I.V. infusion 5 mg (as monohydrate) in 100 mL | Injection |
Zolmitriptan | Tablet 2.5 mg | Oral |
Zonisamide | Capsule 100 mg | Oral |
| Capsule 25 mg | Oral |
| Capsule 50 mg | Oral |
Zuclopenthixol decanoate | Oily I.M. injection 200 mg in 1 mL | Injection |
